Document:

Exhibit 10.2

    
      

    

    Exhibit
      10.2

    APPENDIX
      6.5. 

     

    TO
      SPA
      AMONG IDO SECURITY LTD, THE MEDICAL EXCHANGE INC ET.AL.

     

    
      
        EMPLOYMENT
          AGREEMENT

      

    

     

    THIS
      AGREEMENT
      is made
      as of __ ______________ , 2006

     

    B
      E T W E
      E N:

     

    IDO
      SECURITY LTD.,
      a
      corporation incorporated under the laws of Israel.

     

    (jointly
      the “Corporation”)

     

    and
      -

     

    GILL
      STISS,
      of
      Ashdod, Israel

     

    (the
      “Employee”)

     

    CONTEXT
      OF THIS AGREEMENT

     

    A.  The
      Corporation designs, develops, manufactures and sells prototypes, products,
      know-how and technologies used in security applications.

     

    B.  The
      Employee has been employed by the Corporation since 2005 and the Corporation
      wishes to employ the Employee upon the terms and conditions as set out
      herein.

     

    FOR
      VALUE RECEIVED,
      the
      sufficiency of which is acknowledged, the parties agree as follows:

     

         
      PART 1  

    INTERPRETATION

     

    1.1  Definitions.
      In this
      Agreement, the following terms shall have the following meanings:

     

    “Agreement”
      means
      this agreement and all schedules attached hereto and all amendments made hereto
      and thereto in writing by the parties.

     

    “Business
      Day”
means
      a
      day other than a Saturday or statutory holiday in the State of
      Israel.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    “Person”
      includes individuals, corporations, limited partnerships, general partnerships,
      joint stock companies, joint ventures, associations, companies, trusts or other
      organizations, whether or not legal entities.

     

    1.2  Entire
      Agreement.
      This
      Agreement together with the agreements and other documents to be delivered
      pursuant to this Agreement (or other agreements pertaining to employee benefits,
      including, without limitation, stock option and bonus plan agreements),
      constitute the entire agreement between the parties pertaining to the subject
      matter of this Agreement and supersede all prior agreements, understandings,
      negotiations and discussions, whether oral or written, of the parties and there
      are no warranties, representations or other agreements between the parties
      in
      connection with the subject matter of this Agreement except as specifically
      set
      forth in this Agreement and any document delivered pursuant to this Agreement.
      No supplement, modification or waiver or termination of this Agreement shall
      be
      binding unless executed in writing by the party to be bound
      thereby.

     

    1.3  Sections
      and Headings.
      The
      division of this Agreement into parts and sections and the insertion of headings
      are for convenience of reference only and shall not affect the construction
      or
      interpretation of this Agreement. The terms “this
      Agreement”,
      “hereof”,
      “hereunder”
      and similar expressions refer to this Agreement and not to any particular
      article, section or other portion hereof and include any agreement or instrument
      supplemental or ancillary hereto. Unless something in the subject matter or
      context is inconsistent therewith, references herein to parts and sections
      are
      to parts and sections of this Agreement.

     

    1.4  Number
      & Gender.
      Words
      importing the singular number only shall include the plural and vice versa
      and
      words importing the masculine gender shall include the feminine and neuter
      genders and vice versa.

     

    1.5  Applicable
      Law.
      This
      Agreement shall be construed and enforced in accordance with the laws of the
      State of Israel applicable therein.

     

    1.6  Currency.
      Unless
      otherwise specified, all references herein to currency shall be references
      to
      currency of Israel.

     

    1.7  Calculation
      of Time.
      When
      calculating the period of time within which or following which any act is to
      be
      done or step taken pursuant to this Agreement, the date which is the reference
      date in calculating such period shall be excluded. If the last day of such
      period is a non Business Day, the period in question shall end on the next
      Business Day. 

     

        
      PART 2  

    APPOINTMENT
      AND DUTIES

     

    2.1  Appointment.
      The
      Corporation agrees to employ the Employee as its Chief Technology Officer upon
      the terms and conditions contained herein and the Employee accepts such
      appointment.

     

    2.2  Term.
      The
      employment of the Employee hereunder shall commence on the date hereof and
      shall
      continue for an initial term of three years (the “Initial Term”) unless
      terminated in accordance with the provisions of this Agreement. This Agreement
      shall be renewed for successive two year terms (each a “Renewal Term”) unless
      the Corporation or Employee indicates in writing, more than 120 days prior
      to
      the termination of this Initial term or any Renewal term, that it does not
      intend to renew this Agreement. 

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    2.3  Duties
      and Reporting.
      The
      Employee will report directly to the board of directors of the Corporation
      and
      shall carry out all duties and responsibilities which are from time to time
      assigned to him by the board of directors.

     

    PART
      3  

    BENEFITS
      &
      EXPENSES

     

    3.1     
      Gross
      Salary.
      During
      the term hereof, and subject to the performance of the services required to
      be
      performed hereunder by Employee, the Corporation shall pay to the Employee
      for
      all services rendered hereunder, as salary, payable not less often than once
      per
      month and in accordance with the Corporation 's normal and reasonable payroll
      practices, a monthly salary equal to NISNIS 60,000 “employer’s cost”, according
      to which the employee’s gross salary shall be calculated (the "Gross Salary")
      linked to increases in the consumer price index. This salary shall be reviewed
      periodically and may be favorably adjusted along with other benefits
      accordingly.

    

    3.2     
      Bituach
      Menahalim
      The
      Employee may subsequently decide that the Corporation and the Employee will
      obtain and maintain Manager’s Insurance (Bituach Menahalim) and Professional
      Disability Insurance for the exclusive benefit of the Employee in the customary
      form. Each of the Corporation and the Employee shall contribute toward the
      premiums payable in respect of such insurance those amounts which would be
      recognized under applicable law, but in no event shall such contributed amounts
      be more than thirteen and one third percent (13 1/3%) of each monthly Gross
      Salary payment from the Corporation and five percent (5 %) of such amount from
      the Employee. On termination for any reason, Corporation shall assign all such
      policies to Employee which shall include all amounts of the funds and benefits
      accrued under such policies, subject to clause 3.7 herein. The Corporation
      shall
      execute required documentation to effect this clause. It shall be clear that
      any
      amount paid by the Corporation under the provisions of this section 3.2 shall
      be
      included in Corporation’s total costs under this Part 3 of not more than NIS
      60,000.

    

    3.3     
      Keren
      Heshtamlut
      The
      Employee may subsequently decide that the Corporation and the Employee shall
      maintain an advancement fund (keren Heshtamlut) for exclusive benefit of the
      Employee. The Corporation shall contribute to such fund an amount equal to
      7-1/2% of each monthly Gross Salary payment and the employee shall contribute
      to
      such fund an amount equal to 2-1/2% of each monthly Gross Salary payment. The
      Employee hereby instructs the Corporation to transfer to such advancement fund
      the amount of the Employee’s and the Corporation ’s contribution from each
      monthly Gross Salary payment. Employee can elect to receive any part of the
      Corporation’s contribution in cash should this be more efficient for tax
      purposes at the Employee’s election. On termination for any reason, Employee
      will be eligible to receive all amounts accrued in the fund subject to clause
      3.7 herein. The Corporation shall execute required documentation to effect
      this
      clause. It shall be clear that any amount paid by the Corporation under the
      provisions of this section 3.3 shall be included in Corporation’s total costs
      under this Part 3 of not more than NIS 60,000.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    

    3.4     
      Car,
      Cell Phone.
      The
      Employee may subsequently decide to include car and cell phone rights hereunder
      provided such amounts paid therefore shall be included in Corporation’s total
      costs under this Part 3 of not more than NIS 60,000.

    

    3.5     
      Expenses
      All
      expenses reasonably incurred by the Employee shall be reimbursed, together
      with
      any applicable sales and goods and services taxes, by the Corporation within
      10
      Business Days after presentation by the Employee of proper invoices and receipts
      in keeping with the policies of the Corporation as established from time to
      time. 

    

    3.6     
      Vacation.
      The
      Employee shall be entitled to an aggregate of 28 business days of paid vacation
      per contract year, to be taken at times that are mutually agreeable to the
      parties. In addition, the Employee shall be entitled to all paid holidays given
      by the Company to its employees. Vacation days shall be prorated for any portion
      of a year to the date of termination. Any unutilized vacation days shall accrue
      from year to year and at Employee’s option any unused portion may be redeemed.

    

    3.7     
      Differences.
      The
      Employee hereby acknowledges and declares that the Employee’s rights regarding
      Bituach Menahalim and Keren Heshtamlut and Professional Disability Insurance
      have not been paid in full to the date of this agreement and that an amount
      of
      480,000 NIS is missing as the Company has not paid into the said funds and
      Insurance all of the necessary and required amounts (“the
      Differences”).
      The Employee acknowledges that the non payment of the Differences mentioned
      above was approved by the Employee as the majority shareholder and Managing
      Director of the Corporation. The Employee explicitly agrees and declares that
      he
      does not have and will have any claim whatsoever against the Corporation or
      any
      person on behalf of the Corporation including the Corporation shareholders
      and/or officers regarding amongst others the non timely payment of the
      Differences and waives any rights whatsoever with regard to the Differences.
      Notwithstanding the above the Employee and Corporation agree that the
      Differences are to be paid by the Corporation only in the event that the
      Employee is entitled to severance pay in accordance with the law and the
      provisions herein. Subject to such right the Corporation will pay the
      Differences within 30 days from the date that Employee is entitled to said
      severance pay. 

    

    Severence
      Pay.
      The
      Employee acknowledges that in the event that the Employee’s employment is
      terminated in a manner that the Employee is entitled to severance pay in
      accordance with the law and the provisions herein then severance pay will be
      calculated and paid notwithstanding the provisions of The Severance Payment
      Law
      1963, in the following manner: for the period of employment up to the date
      of
      this Agreement the amount deposited on account of severance pay in the Bituach
      Minhalim policy of the Employee as of the date of this Agreement (plus the
      Bituach Minhalim component of the Differences as noted above) and for the period
      from the date herein the last monthly Gross Salary multiplied by the year/s
      or
      part thereof from the date herein. The Employee acknowledges that the severance
      pay paid to the Employee is and will be less than the amount proscribed by
      law
      and notwithstanding the Employee agrees to the provision herein. The Employee
      acknowledges that The Medical Exchange Inc., a Nevada company and the Purchaser
      defined in the Securities Purchase Agreement entered into with the Corporation,
      amongst others, as of the date hereof, entered such agreement and invested
      in
      the Corporation based upon, inter alia, the declaration of the Employee that
      the
      Employee waives rights to full severance pay as set forth herein. The Employee
      herein undertakes to fully indemnify the Corporation and/or the said Purchaser
      in the event that the Employee shall claim any money regarding Severance Pay
      that is not in accordance with this provision. 

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    Provided
      however that in the event that Employee resigns without just cause after ten
      months from the date hereof or the Company or the Employee does not agree to
      renew this Agreement for any Renewal Term then the Employee is entitled to
      Severence Pay as provided and calculated as stated above.

    

    PART
      4

    EMPLOYEE’S
      COVENANTS

    

    4.1     
      Service.
      The
      Employee shall devote the whole of his time, attention and ability to the
      business of the Corporation and shall well and faithfully serve the Corporation
      and shall use his best efforts to promote the interests of the Corporation.
      The
      Employee appreciates that the Employee’s duties may involve significant travel
      from the Employee’s place of employment, and the Employee agrees to travel as
      reasonably required in order to fulfill the Employee’s duties. The Employee may
      work up to 10% of his time at Shikumit Ltd. as general manager.

     

    4.2     
      Duties
      and Responsibilities.
      The
      Employee shall duly and diligently perform all the duties assigned to him while
      in the employ of the Corporation, and shall truly and faithfully account for
      and
      deliver to the Corporation all money, securities and things of value belonging
      to the Corporation which the Employee may from time to time receive for, from
      or
      on account of the Corporation.

     

    4.3     
      Rules
      and Regulations.
      The
      Employee shall be bound by and shall faithfully observe and abide by all the
      rules and regulations of the Corporation from time to time in force which are
      brought to his notice.

     

    PART
      5

    CONFIDENTIAL
      INFORMATION AND DEVELOPMENTS

     

    5.1     
      “Confidential
      Information”
      means
      information, whether or not originated by the Employee, that relates to the
      business or affairs of the Corporation, its affiliates, clients or suppliers
      and
      is confidential or proprietary to, about or created by the Corporation, its
      affiliates, clients, or suppliers. Confidential Information includes, but is
      not
      limited to, the following types of confidential information and other
      proprietary information of a similar nature (whether or not reduced to writing
      or designated or marked as confidential):

     

    
      	(i)  
               	
              work
                product resulting from or related to work or projects performed for
                or to
                be performed for the Corporation or its affiliates, including but
                not
                limited to, the interim and final lines of inquiry, hypotheses, research
                and conclusions related thereto and the methods, processes, procedures,
                analysis, techniques and audits used in connection therewith;
                

            

    

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    
      	(ii)  
               	
              computer
                software of any type or form and in any stage of actual or anticipated
                development, including but not limited to, programs and program modules,
                routines and subroutines, procedures, algorithms, design concepts,
                design
                specifications (design notes, annotations, documentation, flowcharts,
                coding sheets, and the like), source code, object code and load modules,
                programming, program patches and system
                designs;

            

    

     

    
      	(iii) 
                	
              information
                relating to developments (as hereinafter defined) prior to any public
                disclosure thereof, including but not limited to, the nature of the
                developments, production data, technical and engineering data, test
                data
                and test results, the status and details of research and development
                of
                products and services, and information regarding acquiring, protecting,
                enforcing and licensing proprietary rights (including patents, copyrights
                and trade secrets);

            

    

     

    
      	(iv)  
               	
              internal
                Corporation personnel and financial information, vendor names and
                other
                vendor information, purchasing and internal cost information, internal
                services and operational manuals, and the manner and method of conducting
                the Corporation’s business;

            

    

     

    
      	(v)  
               	
              marketing
                and development plans, price and cost data, price and fee amounts,
                pricing
                and billing policies, quoting procedures, marketing techniques and
                methods
                of obtaining business, forecasts and forecast assumptions and volumes,
                and
                future plans and potential strategies of the Corporation that have
                been or
                are being discussed; and

            

    

     

    
      	(vi)  
               	
              all
                information that becomes known to the Employee as a result of employment
                that the Employee, acting reasonably, believes is confidential information
                or that the Corporation takes measures to
                protect.

            

    

     

    5.2     
      Confidential
      Information does not include:

     

    
      	(vii)  
               	
              the
                general skills and experience gained during the Employee’s employment or
                engagement with the Corporation that the Employee could reasonably
                have
                been expected to acquire in similar employment or engagements with
                other
                companies;

            

    

     

    
      	(viii)  
               	
              information
                publicly known without breach of this Agreement or similar agreements;
                or

            

    

     

    
      	(ix)  
               	
              information,
                the disclosure of which is required to be made by any law, regulation,
                governmental authority or court (to the extent of the requirement),
                provided that before disclosure is made, notice of the requirement
                is
                provided to the Corporation, and to the extent of the requirement,
                (to the
                extent reasonably possible in the circumstances) the Corporation
                is
                afforded an opportunity to dispute the
                requirement.

            

    

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    5.3     
      “Developments”
      means
      all discoveries, inventions, designs, works of authorship, improvements and
      ideas (whether or not patentable or copyrightable) and legally recognized
      proprietary rights (including, but not limited to, patents, copyrights,
      trademarks, topographies, know how and trade secrets), and all records and
      copies of records relating to the foregoing, that relates solely to the
      Corporation’s business and improvements and modifications to it:

     

    
      	(x) 
                	
              result
                or derive from the Employee’s employment or from the Employee’s knowledge
                or use of Confidential Information;

            

    

     

    
      	(xi)  
               	
              are
                conceived or made by the Employee (individually or in collaboration
                with
                others) during the term of the Employee’s employment by the Corporation in
                line with work of Employee or connected to Corporation’s
                business;

            

    

     

    
      	(xii)  
               	
              result
                from or derive from the use or application of the resources of the
                Corporation or its affiliates; or

            

    

     

    
      	(xiii) 
                	
              relate
                to the business operations of or actual or demonstrably anticipated
                research and development by the Corporation or its
                affiliates.

            

    

     

    For
      greater certainty, discoveries, inventions, designs, works of authorship,
      improvements and ideas (whether or not patentable or copyrightable) of the
      Employee that do not relate to the business of the Corporation are not the
      subject matter of this Agreement.

     

    PART
      6

    NO
      CONFLICTING OBLIGATIONS

     

    6.1     
      The
      Employee warrants to the Corporation that:

     

    
      	(xiv)  	
              the
                performance of the Employee’s duties as an employee of the Corporation
                will not breach any agreement or other obligation to keep confidential
                the
                proprietary information of any other party;
                and

            

    

     

    
      	(xv)  	
              the
                Employee is not bound by any agreement with or obligation to any
                other
                party that conflicts with the Employee’s obligations as an employee of the
                Corporation or that may affect the Corporation’s interest in the
                Developments.

            

    

     

    6.2     
      The
      Employee will not, in the performance of the Employee’s duties as an employee of
      the Corporation:

     

    
      	(xvi)  	
              improperly
                bring to the Corporation or use any trade secrets, confidential
                information or other proprietary information of any other party;
                or

            

    

     

    
      	(xvii)  	
              knowingly
                infringe the intellectual property rights of any other
                party.

            

    

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    PART
      7

    COMPETITION
      AND SOLICITATION

     

    7.1     
      Definitions.

     

    “Competitive
      Business”
      means
      any business that supplies products or services competitive with those then
      supplied by the Corporation or which the Corporation was contemplating supplying
      when the Employee was employed by the Corporation. 

     

    “Employment
      Period”
      means
      the period during which the Employee is employed by the Corporation.

     

    “Termination
      Date”
      means
      the date that the Employee’s employment with the Corporation is terminated
      or expires in accordance with Section 2.2 or Part 12.

     

    

    7.2     
      Non-Competition.
      The
      Employee acknowledges that employment by the Corporation will give the Employee
      access to the Confidential Information, and that the Employee’s knowledge of the
      Confidential Information will enable the Employee to put the Corporation at
      a
      significant competitive disadvantage if the Employee is employed or engaged
      by
      or becomes involved in a Competitive Business. Accordingly, during the
      Employment Period and for one year after the Termination Date, the Employee
      will
      not, directly or indirectly, individually or in partnership or in conjunction
      with any other Person:

     

    (i)
      be
      engaged, directly or indirectly, in any manner whatsoever, including, without
      limitation, either individually or in partnership, jointly or in conjunction
      with any other person, or as an employee, consultant, adviser, principal, agent,
      member or proprietor in any Competitive Business;

    

    (ii)
      be
      engaged, directly or indirectly, in any manner whatsoever, including, without
      limitation, either individually or in partnership, jointly or in conjunction
      with any other person, or as an employee, consultant, adviser, principal, agent,
      member or proprietor in any Competitive Business in a capacity in which the
      loyal and complete fulfilment of the Employee’s duties to that Competitive
      Business would (i) inherently require that the Employee use, copy or transfer
      Confidential Information, or (ii) make beneficial any use, copy or transfer
      of
      Confidential Information; or

    

    (iii)
      advise, invest in, lend money to, guarantee the debts or obligations of, or
      otherwise have any other financial or other interest (including an interest
      by
      way of royalty or other compensation arrangements) in or in respect of any
      Person which carries on a Competitive Business.

    

    The
      restriction in Subsection 7.2 (iii) will not prohibit the Employee from holding
      not more than 5% of the issued shares of a public company listed on any
      recognized stock exchange or traded on any bona
      fide
      "over
      the counter" market anywhere in the world.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    

    For
      greater certainty, the Employee’s obligations under this Section are in addition
      to the obligations respecting disclosure and use of Confidential Information
      in
      Part 8.

    

    7.3     
      No
      Solicitation of Clients and Suppliers.
      The
      Employee acknowledges the importance to the business carried on by the
      Corporation of the client and supplier relationships developed by it and the
      unique opportunity that the Employee’s employment and the Employee’s access to
      the Confidential Information offers to interfere with these relationships.
      Accordingly, the Employee will not during the Employment Period and for a period
      of 12 months thereafter directly or indirectly, contact or solicit any person
      who the Employee knows to be a prospective, current or former client or supplier
      of Corporation (who, in the case of a former client or supplier of the
      Corporation, has had dealings with the Corporation at any time during the 12
      month period immediately prior to the end of the Employment Period) for the
      purpose of selling to the client or buying from the supplier any products or
      services that are the same as or substantially similar to, or in any way
      competitive with, the products or services sold or purchased by Corporation
      during the Employee’s employment or at the end thereof, as the case may
      be.

     

    7.4     
      No
      Solicitation of Employees.
      The
      Employee acknowledges the importance to the business carried on by the
      Corporation of the human resources engaged and developed by it and the unique
      access that the Employee’s employment offers to interfere with these resources.
      Accordingly, the Employee will not during the Employment Period and for a period
      of 12 months thereafter, induce or solicit, attempt to induce or solicit or
      assist any third party in inducing or soliciting any employee or consultant
      of
      the Corporation, to leave the Corporation or to accept employment or engagement
      elsewhere.

     

    7.5     
      Independent
      Covenants.
      Each of
      Subsections 7.2 and 7.3 will be construed as constituting obligations
      independent of any other obligations in this Agreement. The existence of any
      claim or cause of action the Employee may have or assert against the
      Corporation, whether based on this Agreement or otherwise, will not constitute
      a
      defence to the enforcement by the Corporation of any of the covenants and
      agreements in the foregoing sections.

     

    PART
      8

    CONFIDENTIAL
      INFORMATION

     

    8.1     
      Protection
      of Confidential Information.
      All
      Confidential Information, whether it is developed by the Employee during the
      Employment Period or by others employed or engaged by or associated with the
      Corporation or its affiliates or clients, is the exclusive and confidential
      property of the Corporation or its affiliates or clients, as the case may be,
      and will at all times be regarded, treated and protected as such, as provided
      in
      this Agreement.

     

    8.2     
      Covenants
      Respecting Confidential Information.
      As a
      consequence of the acquisition of Confidential Information, the Employee will
      occupy a position of trust and confidence with respect to the affairs and
      business of the Corporation and its affiliates and clients. In view of the
      foregoing, it is reasonable and necessary for the Employee to make the following
      covenants regarding the Employee’s conduct during and subsequent to the
      Employee’s employment by the Corporation.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    8.3     
      Non
      Disclosure.
      At all
      times during and subsequent to the Employee’s employment with the Corporation,
      the Employee will not disclose Confidential Information to any Person (other
      than as necessary in carrying out the Employee’s duties on behalf of the
      Corporation) without first obtaining the Corporation’s consent, and the Employee
      will take all reasonable precautions to prevent inadvertent disclosure of any
      Confidential Information. This prohibition includes, but is not limited to,
      disclosing or confirming the fact that any similarity exists between the
      Confidential Information and any other information.

     

    8.4     
      Using,
      Copying, etc.
      At all
      times during and subsequent to the Employee’s employment with the Corporation,
      the Employee will not use, copy, transfer or destroy any Confidential
      Information (other than as necessary in carrying out the Employee’s duties on
      behalf of the Corporation) without first obtaining the Corporation’s consent,
      and the Employee will take all reasonable precautions to prevent inadvertent
      use, copying, transfer or destruction of any Confidential Information. This
      prohibition includes, but is not limited to, licensing or otherwise exploiting,
      directly or indirectly, any products or services that embody or are derived
      from
      Confidential Information or exercising judgment or performing analysis based
      upon knowledge of Confidential Information.

     

    8.5     
      Return
      of Confidential Information.
      Within
      2 Business Days after the termination of the Employee’s employment on any basis
      and of receipt by the Employee of the Corporation’s written request, the
      Employee will promptly deliver to the Corporation all property of or belonging
      to or administered by Corporation including without limitation all Confidential
      Information that is embodied in any physical or ephemeral form, whether in
      hard
      copy or on magnetic media, and that is within the Employee’s possession or under
      the Employee’s control.

     

    8.6     
      Obligations
      Continue.
      The
      Employee’s obligations under this Part 8 are to remain in effect in
      perpetuity.

     

    PART
      9

    INTELLECTUAL
      PROPERTY

     

    9.1     
      Ownership.
      All
      Developments will be the exclusive property of the Corporation and the
      Corporation will have sole discretion to deal with Developments. For greater
      certainty, all work done during the Employment Period by the Employee for the
      Corporation or its affiliates is a work for hire of which the Corporation or
      its
      affiliate, as the case may be, is the first author for copyright purposes and
      in
      respect of which all copyright will vest in the Corporation or the relevant
      affiliate, as the case may be.

     

    9.2     
      Records.
      The
      Employee will keep complete, accurate and authentic notes, reference materials,
      data and records of all Developments in the manner and form requested by the
      Corporation. All these materials will be Confidential Information upon their
      creation.

     

    9.3     
      Moral
      Rights.
      The
      Employee hereby irrevocably waives all moral rights arising under statute in
      any
      jurisdiction or under common law which the employee may have now or in the
      future with respect to the Developments, including, without limitation, any
      rights the Employee may have to have the Employee’s name associated with the
      Developments or to have the Employee’s name not associated with the
      Developments, any rights the Employee may have to prevent the alteration,
      translation or destruction of the Developments, and any rights the Employee
      may
      have to control the use of the Developments in association with any product,
      service, cause or institution. The Employee agrees that this waiver may be
      invoked by the Corporation, and by any of its authorized agents or assignees,
      in
      respect of any or all of the Developments and that the Corporation may assign
      the benefit of this waiver to any Person.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    9.4     
      Further
      Assurances.
      The
      Employee will do all further things that may be reasonably necessary or
      desirable in order to give full effect to the foregoing. If the Employee’s
      co-operation is required in order for the Corporation to obtain or enforce
      legal
      protection of the Developments following the termination of the Employee’s
      employment, the Employee will provide that co-operation so long as the
      Corporation pays to the Employee reasonable compensation for the Employee’s time
      at a rate to be agreed, provided that the rate will not be less than the last
      base salary or compensation rate paid to the Employee by the Corporation during
      the Employee’s employment.

     

    PART
      10

    CONSENT
      TO ENFORCEMENT

     

    The
      Employee confirms that all restrictions in Part 8 and 9 are reasonable and
      valid
      and all defences to the strict enforcement thereof by the Corporation are waived
      by the Employee. Without limiting the generality of the forgoing, the Employee
      hereby consents to an injunction being granted by a court of competent
      jurisdiction in the event that the Employee is in any breach of any of the
      provisions stipulated in Part 8 and 9. The Employee hereby expressly
      acknowledges and agrees that injunctive relief is an appropriate and fair remedy
      in the event of a breach of any of the said provisions.

     

    PART
      11

    WARRANTIES,
      COVENANTS AND REMEDIES

     

    11.1     To
      the
      best knowledge of the Employee the Employee has met all the obligations of
      the
      Employee as set forth in Parts 6 through 9 from the date on which the Employee
      was first employed by Corporation. Any breach or threatened breach of those
      sections by the Employee will constitute Just Cause for immediate termination
      of
      the Employee’s employment or engagement by the Corporation.

     

    11.2     A
      breach
      or threatened breach by the Employee of any of Parts 6 through 9 could result
      in
      unfair competition with the Corporation and could result in the Corporation
      and
      its shareholders suffering irreparable harm that is not capable of being
      calculated and that cannot be fully or adequately compensated by the recovery
      of
      damages alone. Accordingly, the Employee agrees that the Corporation will be
      entitled to interim and permanent injunctive relief, specific performance and
      other equitable remedies, in addition to any other relief to which the
      Corporation may become entitled.

     

    11.3     The
      Employee’s obligations under each of Parts 6 through 9 are to remain in effect
      in accordance with each of their terms and will exist and continue in full
      force
      and effect despite any breach or repudiation, or alleged breach or repudiation,
      of this Agreement or the Employee’s employment (including, without limitation,
      the Employee’s wrongful dismissal) by the Corporation.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    PART
      12

    TERMINATION

     

    12.1     Termination
      by the Employee.
      The
      Employee may terminate this Agreement for any reason upon 90 days prior written
      notice given by the Employee to the Corporation. The Corporation, at its sole
      discretion, may elect to accept the 90 Business Days written notice or to reduce
      or eliminate the notice period. In such event, the Employee’s employment shall
      terminate on the earlier day elected by the Corporation and Corporation shall
      pay to Employee otherwise required as if such notice period has not been
      eliminated or reduced. Upon the termination of employment by the Employee under
      this Section 11.1 the Corporation shall pay to the Employee all bonuses and
      other benefits earned or accrued up to the date of termination, but otherwise
      all obligations of the Corporation under this Agreement shall end.

     

    12.2     Definition
      of  “Just
      Cause”.
“Just
      Cause” means:

     

    (i)
      Employee’s final conviction of, or plea of nolo contendere, to any felony or to
      a crime involving moral depravity or fraud; (ii) Employee’s commission of an act
      of dishonesty or fraud or breach of fiduciary duty or act that has a material
      adverse effect on the name or public image of the Company,; (iii) Employee’s
      commission of an act of willful misconduct or gross negligence,; (iv) the
      material breach of any of Employee’s material obligations under this Agreement ;
      or (v) excessive absenteeism, chronic alcoholism or any other form of addiction
      that prevents Employee from performing the essential functions of his position
      with or without a reasonable accommodation; provided,
      however,
      that
      the Company may terminate Employee’s employment forJust Cause, as to (iv) or (v)
      above, only after failure by Employee to correct or cure, or to commence or
      to
      continue to pursue the correction or curing of, such conduct or omission within
      ten (10) days after receipt by Employee of written notice by the Company of
      each
      specific claim of any such misconduct or failure. 

     

    12.3     Termination
      by the Corporation for Just Cause.
      The
      Corporation may terminate this Agreement at any time for Just Cause without
      notice and (except as provided in the immediately following sentence) without
      payment of any compensation by way of anticipated earnings, damages, or other
      relief of any kind whatsoever. Upon the termination of employment by the
      Corporation for Just Cause, the Corporation shall pay to the Employee all
      salaries, bonuses, vacation and other benefits earned or accrued up to the
      date
      of termination, but otherwise all obligations of the Corporation under this
      Agreement end.

     

    12.4     Termination
      or Decision not to Renew by the Corporation for Other Than Just
      Cause.
      The
      Corporation may terminate this Agreement at any time for other than Just Cause
      or decide not to renew this Agreement upon any renewal date for other than
      Just
      Cause upon the following terms:

     

    (b)  if
      the
      Corporation so terminates this Agreement at any time during the Initial Term
      of
      this Agreement, the Corporation shall pay to the Employee an amount equal to
      the
      Gross Salary and other benefits which Employee received monthly prior to
      termination payable for the period from the date of such termination to the
      end
      of the Initial Term as if the Agreement had not been so terminated ;
      and

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (b)  
if
      the
      Corporation so terminates this Agreement during a Renewal Term the Corporation
      shall pay the Employee an amount equal to the Gross Salary and other benefits
      which Employee received monthly prior to termination then payable for the period
      from the date of such termination to the end of the Renewal Term as if the
      Agreement had not been so terminated; and

     

    (c)  
      upon any such termination or failure to renew, all
      bonuses or other benefits earned or accrued up to the date of termination or
      expiry shall be paid by the Corporation, but except for such payments and the
      payments to be made pursuant to Sections 12.4(a) or (b), as applicable, all
      obligations of the Corporation under this Agreement shall end upon such
      termination or failure to renew. Payments under Sections 12.4(a) or (b) shall
      be
      payable monthly subject to deductions required under law.

     

    12.5     Termination
      by the Employee for Good Reason.
      The
      Employee may terminate this Agreement at any time upon the occurrence of any
      of
      the following events (each a “Good
      Reason”),
      if
      such occurrence takes place without the express written consent of the
      Employee:

     

    
      	(i)  
               	
              a
                change in the Employee’s title or position or a material diminution in the
                Employee’s duties or the assignment to the Employee of duties which
                materially impairs the Employee’s ability to function in his current
                capacity for the Corporation, or, with respect an assignment of duties
                only, is materially inconsistent with his
                duties;

            

    

     

    
      	(ii)  
               	
              any
                material change in the Employee’s direct reporting obligations;
                

            

    

    
       

      
        	(iii)  
                 	
                or
                  any other occurrence recognized by The Severence Pay Law 1963 as
                  entitling
                  Employee to severence pay.

              

      

       

    

    In
      the
      event that the Employee terminates this Agreement for Good Reason, he shall
      be
      entitled to the same payments and benefits as provided in Section 12.4 of this
      Agreement as if the Corporation had terminated this Agreement at the time that
      the Employee terminates this Agreement under this Section 12.5.

     

    12.6     Full
      and Final Release.
      In
      order to be eligible for the payments as set forth in this Section 12 the
      Employee must (i) execute and deliver to the Corporation a general release,
      in a
      form satisfactory to the Corporation, and (ii) be and remain in full compliance
      with his obligations under this Agreement. 

     

    12.7     Fair
      and Reasonable.
      The
      parties confirm that the provision contained in Sections 12.4 and 12.5 are
      fair
      and reasonable and that all such payments shall be in full satisfaction of
      all
      claims which the Employee may otherwise have at law against the Corporation
      including, or in equity by virtue of such termination of
      employment.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    12.8     Return
      of Property.
      Upon
      the termination of the Employee’s employment for any reason whatsoever, the
      Employee shall at once deliver or cause to be delivered to the Corporation
      all
      books, documents, effects, money, computer equipment, computer storage media,
      securities or other property belonging to the Corporation or for which the
      Corporation is liable to others, which are in the possession, charge, control
      or
      custody of the Employee.

     

    12.9     Provisions
      Which Operate Following Termination.
      Notwithstanding any termination of this Agreement for any reason whatsoever,
      the
      following provisions of this Agreement shall continue in full force and effect:
      Parts 1, 5, 7-13 and 15. 

     

    12.10   Board.
      Notwithstanding the foregoing, the termination of Employee’s employment
      hereunder for Cause shall automatically be deemed as Employee’s resignation from
      the Board of Directors of the Corporation and any affiliates without any further
      action, except when the Board shall, in writing, request a continuation of
      duty
      as a Director in its sole discretion.

     

    12.11 
      Without
      derogating from the terms of this Agreement, and particularly the terms of
      Part
      12 to this Agreement, in the event that Company terminates Employee without
      Cause or Employee terminates this Agreement with Good Reason during the Initial
      Term or Employee terminates this Agreement for any reason after the Initial
      Term
      then the Employee shall not require Consent under Section 2.7 of the Stock
      Purchase Agreement dated June 5, 2006 between the Employee and The Medical
      Exchange Inc. after 180 days from such termination. Furthermore, ifthe Company
      or Employee does not agree to renew this Agreement for any Renewal Term then
      the
      Employee shall not require Consent under Section 2.7 of the said Stock Purchase
      Agreement after 180 days from expiration of the Initial Term. 

     

    PART
      13

    GENERAL

     

    13.1   
      Benefit
      & Binding.
      This
      Agreement shall enure to the benefit of and be binding upon the respective
      successors and permitted assigns of the parties hereto.

     

    13.2   
      Amendments
      & Waivers.
      No
      amendment to this Agreement shall be valid or binding unless set forth in
      writing and duly executed by all of the parties hereto. No waiver of any breach
      of any provision of this Agreement shall be effective or binding unless made
      in
      writing and signed by the party purporting to give the same and, unless
      otherwise provided in the written waiver, shall be limited to the specific
      breach waived.

     

    13.3   
      Assignment.
      Neither
      this Agreement nor the rights and obligations hereunder shall be assignable
      by
      either party without the consent of the other.

     

    13.4   
      Severability.
      If any
      provision of this Agreement is determined to be invalid or unenforceable in
      whole or in part, such invalidity or unenforceability shall attach only to
      such
      provision and all other provisions hereof shall continue in full force and
      effect.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    13.5   
      Attornment.
      For the
      purposes of all legal proceedings this Agreement shall be deemed to have been
      performed in the State of Israel and the labour courts of Tel Aviv- Jaffa shall
      have jurisdiction to entertain any action arising under this
      Agreement.

     

    PART
      14

    ACKNOWLEDGEMENT

     

    The
      Employee acknowledges that:

     

    
      	(iii) 
                	
              the
                Employee has received a copy of this
                Agreement;

            

    

     

    
      	(iv)  
               	
              the
                Employee has had sufficient time to review and consider this Agreement
                thoroughly;

            

    

     

    
      	(v) 
                	
              the
                Employee has read and understands the terms of this Agreement and
                his
                obligations under this Agreement;

            

    

     

    
      	(vi)  
               	
              the
                restriction placed upon the Employee by this Agreement are reasonably
                necessary to protect the Corporation’s proprietary interests in the
                Confidential Information and the Developments and will not preclude
                the
                Employee from being gainfully employed in a suitable capacity following
                the termination of the Employee’s employment, give the Employee’s
                knowledge and experience;

            

    

     

    
      	(vii)  
               	
              the
                Employee has been given an opportunity to obtain independent legal
                advice,
                or such other advice as the Employee may desire, concerning the
                interpretation and effect of this Agreement and by signing this Agreement
                the Employee has either obtained advice or voluntarily waived the
                Employee’s opportunity to receive the same;
                and

            

    

     

    
      	(viii)  
               	
              this
                Agreement is entered into voluntarily by the
                Employee.

            

    

     

    PART
      15

    NOTICES

     

    Any
      demand, notice or other communication (the “Notice”)
      to be
      given in connection with this Agreement shall be given in writing on a Business
      Day and may be given by personal delivery or by transmittal by facsimile
      addressed to the recipient as follows:

     

    
      	
              To
                the Corporation:

            	
              IDO
                Security 2000 Ltd.

              6
                Sapir St., Reshon-Lezion

              Isarel

            
	 	 
	
              To
                the Employee:

            	
              Mr.
                Gil Stiss

              41
                Nahal Lacish St., Asdod

              Israel

            

    

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    or
      such
      other address or facsimile number as may be designated by notice by any party
      to
      the other. Any Notice given by personal delivery will be deemed to have been
      given on the day of actual delivery and if transmitted by facsimile before
      3:00
      pm on a Business Day, will be deemed to have been given on that Business Day
      and
      if transmitted by facsimile after 3:00 pm on a Business Day, will be deemed
      to
      have been given on the next Business Day after the date of
      transmission.

     

    PART
      16

    FURTHER
      ASSURANCES

     

    The
      parties shall from time to time execute and deliver all such further documents
      and do all acts and things as the other party may reasonably require to
      effectively carry out or better evidence or perfect the full intent and meaning
      of this Agreement.

     

    PART
      17

    FAX
      SIGNATURES

     

    This
      Agreement may be signed either by original signature or by facsimile
      signature.

     

    PART
      18

    COUNTERPARTS

     

    This
      Agreement may be executed by the parties in one or more counterparts, each
      of
      which when so executed and delivered shall be an original and such counterparts
      shall together constitute one and the same instrument.

     

    IN
      WITNESS WHEREOF
      the
      parties have duly executed this Agreement.

     

    
      	 	 	 	 IDO
              SECURITY LTD.
	 	 	 	 
	
            	 	 	
              

              Per:

            
	 	 	 	 
	 	 	 	 

              

              GIL
                STISS

            

    

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

     

    The
      undersigned hereby consents to the provisions of Section 12.11
      above.

     

     

    The
      Medical Exchange Inc.

     

    

    ________________________

     

    
      
        
        

      

      
        17Exhibit 10.3

    
      
        

      

      EXHIBIT
        10.3

    

     

    SUBSCRIPTION
      AGREEMENT

     

    THIS
      SUBSCRIPTION AGREEMENT
      (this
“Agreement”),
      dated
      as of February ____, 2007, by and among The Medical Exchange Inc., a Nevada
      corporation (the “Company”),
      and
      the subscribers identified on the signature page hereto (each a “Subscriber”
and
      collectively “Subscribers”).

     

    WHEREAS,
      the
      Company and the Subscribers are executing and delivering this Agreement in
      reliance upon an exemption from securities registration afforded by the
      provisions of Section 4(2), Section 4(6) and/or Regulation D (“Regulation
      D”)
      as
      promulgated by the United States Securities and Exchange Commission (the
“Commission”)
      under
      the Securities Act of 1933, as amended (the “1933
      Act”).

     

    WHEREAS,
      the
      parties desire that, upon the terms and subject to the conditions contained
      herein, the Company shall issue and sell to the Subscribers, as provided herein,
      and the Subscribers, in the aggregate, shall purchase for a minimum of
      $1,000,000 and a maximum of up to $3,000,000 (the “Purchase
      Price”)
      of up
      to $3,260,869.50 (the “Principal
      Amount”)
      of
      principal amount of promissory notes of the Company (“Note”
or
      “Notes”),
      a
      form of which is annexed hereto as Exhibit
      A,
      convertible into shares of the Company’s common stock, $0.001 par value (the
“Common
      Stock”)
      at a
      per share conversion price set forth in the Note (“Conversion
      Price”);
      and
      share purchase warrants (the “Warrants”),
      in
      the form annexed hereto as Exhibit
      B,
      to
      purchase shares of Common Stock (the “Warrant
      Shares”).
      The
      Notes, shares of Common Stock issuable upon conversion of the Notes (the
“Shares”),
      the
      Warrants and the Warrant Shares are collectively referred to herein as the
      “Securities”;
      and

     

    WHEREAS,
      the
      aggregate proceeds of the sale of the Notes and the Warrants contemplated hereby
      shall be held in escrow pursuant to the terms of a Funds Escrow Agreement to
      be
      executed by the parties substantially in the form attached hereto as
Exhibit
      C
      (the
“Escrow
      Agreement”).

     

    NOW,
      THEREFORE,
      in
      consideration of the mutual covenants and other agreements contained in this
      Agreement the Company and the Subscribers hereby agree as follows:

     

    1.          
      Closing.
      Subject
      to the satisfaction or waiver of the terms and conditions of this Agreement,
      on
      the Closing Date, Subscriber shall purchase and the Company shall sell to
      Subscriber a Note in the principal amount of $1,000,000 of Purchase Price
      (“First
      Closing Date”)
      designated on the signature page hereto for the purchase price set forth on
      the
      signature page hereto. The consummation of the transactions contemplated herein
      shall take place at the offices of Grushko & Mittman, P.C., 551 Fifth
      Avenue, Suite 1601, New York, New York 10176, as soon as practicable following
      the satisfaction or waiver of all conditions to closing set forth in this
      Agreement (the “Closing
      Date”).
      The
      Company shall have up to sixty (60) additional days after the first Closing
      to
      close on the balance of the Closing Purchase Price in one or more closings.
      The
      Notes and Warrants to be issued on the additional closing dates will have the
      same Maturity Dates and exercise periods, respectively, as the Notes and
      Warrants issued on the First Closing Date. The first such Closing Date shall
      be
      the Closing Date for all amounts representing the Closing Purchase
      Price.

    

    2.         
       Warrants.
      On the
      Closing Date, the Company will issue and deliver Warrants to the Subscribers.
      One Class A Warrant will be issued for each one dollar ($1.00) of Note Principal
      Amount. The per Warrant Share exercise price to acquire a Warrant Share upon
      exercise of a Class A Warrant shall be $5.00. The Warrants shall be exercisable
      until five (5) years after the Actual Effective Date (as defined in Section
      11.1(iv) of this Agreement).

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    3.         
       Security
      Interest.
      The
      Subscribers will be granted a security interest in all the assets of the
      Company, including ownership of Subsidiaries, as defined in Section 5(a) of
      this
      Agreement, and in the assets of the Subsidiaries to be memorialized in a
“Security
      Agreement”,
      a form
      of which is annexed hereto as Exhibit
      D.
      The
      Company will execute such other agreements, documents and financing statements
      reasonably requested by Subscribers, to better effect the Security Agreement
      which will be filed at the Company’s expense with the jurisdictions, states and
      counties designated by the Subscribers. The
      Company will also execute all such documents reasonably necessary in the opinion
      of Subscriber to memorialize and further protect the security interest described
      herein. The Subscribers will appoint a Collateral Agent to represent them
      collectively in connection with the security interest to be granted to the
      Subscribers. The appointment will be pursuant to a “Collateral
      Agent Agreement”,
      a form
      of which is annexed hereto as Exhibit
      E.

    

    4.           Subscriber’s
      Representations and Warranties.
      Each
      Subscriber hereby represents and warrants to and agrees with the Company only
      as
      to such Subscriber that:

     

    (a) 
Organization
      and Standing of the Subscribers.
      If the
      Subscriber is an entity, such Subscriber is a corporation, partnership or other
      entity duly incorporated or organized, validly existing and in good standing
      under the laws of the jurisdiction of its incorporation or organization and
      has
      the requisite corporate power to own its assets and to carry on its
      business.

    

    (b) 
Authorization
      and Power.
      Each
      Subscriber has the requisite power and authority to enter into and perform
      this
      Agreement and to purchase the Notes and Warrants being sold to it hereunder.
      The
      execution, delivery and performance of this Agreement by such Subscriber and
      the
      consummation by it of the transactions contemplated hereby and thereby have
      been
      duly authorized by all necessary corporate or partnership action, and no further
      consent or authorization of such Subscriber or its Board of Directors,
      stockholders, partners, members, as the case may be, is required. This Agreement
      has been duly authorized, executed and delivered by such Subscriber and
      constitutes, or shall constitute when executed and delivered, a valid and
      binding obligation of the Subscriber enforceable against the Subscriber in
      accordance with the terms hereof.

     

    (c) 
No
      Conflicts.
      The
      execution, delivery and performance of this Agreement and the consummation
      by
      such Subscriber of the transactions contemplated hereby or relating hereto
      do
      not and will not (i) result in a violation of such Subscriber’s charter
      documents or bylaws or other organizational documents or (ii) conflict with,
      or
      constitute a default (or an event which with notice or lapse of time or both
      would become a default) under, or give to others any rights of termination,
      amendment, acceleration or cancellation of any agreement, indenture or
      instrument or obligation to which such Subscriber is a party or by which its
      properties or assets are bound, or result in a violation of any law, rule,
      or
      regulation, or any order, judgment or decree of any court or governmental agency
      applicable to such Subscriber or its properties (except for such conflicts,
      defaults and violations as would not, individually or in the aggregate, have
      a
      material adverse effect on such Subscriber). Such Subscriber is not required
      to
      obtain any consent, authorization or order of, or make any filing or
      registration with, any court or governmental agency in order for it to execute,
      deliver or perform any of its obligations under this Agreement or to purchase
      the Notes or acquire the Warrants in accordance with the terms hereof, provided
      that for purposes of the representation made in this sentence, such Subscriber
      is assuming and relying upon the accuracy of the relevant representations and
      agreements of the Company herein.

    

    (d) 
Information
      on Company.
      The
      Subscriber has been furnished with or has had access at the EDGAR Website of
      the
      Commission to the Company’s Form 10-KSB for the year ended June 30, 2006 and all
      periodic reports filed with the Commission thereafter not later than five days
      before the Closing Date (hereinafter referred to as the “Reports”).
      In
      addition, the Subscriber has received in writing from the Company such other
      information concerning its operations, financial condition and other matters
      as
      the Subscriber has requested in writing (such other information is collectively,
      the “Other
      Written Information”),
      and
      considered all factors the Subscriber deems material in deciding on the
      advisability of investing in the Securities. 

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (e)             
       Information
      on Subscriber.
      The
      Subscriber is, and will be at the time of the conversion of the Notes and
      exercise of the Warrants, an “accredited investor”, as such term is defined in
      Regulation D promulgated by the Commission under the 1933 Act, is experienced
      in
      investments and business matters, has made investments of a speculative nature
      and has purchased securities of United States publicly-owned companies in
      private placements in the past and, with its representatives, has such knowledge
      and experience in financial, tax and other business matters as to enable the
      Subscriber to utilize the information made available by the Company to evaluate
      the merits and risks of and to make an informed investment decision with respect
      to the proposed purchase, which represents a speculative investment. The
      Subscriber has the authority and is duly and legally qualified to purchase
      and
      own the Securities. The Subscriber is able to bear the risk of such investment
      for an indefinite period and to afford a complete loss thereof. The information
      set forth on the signature page hereto regarding the Subscriber is
      accurate.

     

    (f)
       
Purchase
      of Notes and Warrants.
      On the
      Closing Date, the Subscriber will purchase the Notes and Warrants as principal
      for its own account for investment only and not with a view toward, or for
      resale in connection with, the public sale or any distribution thereof, but
      Subscriber does not agree to hold the Notes and Warrants for any minimum amount
      of time.

     

    (g) 
Compliance
      with Securities Act.
      The
      Subscriber understands and agrees that the Securities have not been registered
      under the 1933 Act or any applicable state securities laws, by reason of their
      issuance in a transaction that does not require registration under the 1933
      Act
      (based in part on the accuracy of the representations and warranties of
      Subscriber contained herein), and that such Securities must be held indefinitely
      unless a subsequent disposition is registered under the 1933 Act or any
      applicable state securities laws or is exempt
      from such registration. Notwithstanding anything to the contrary contained
      in
      this Agreement, such Subscriber may transfer (without restriction and without
      the need for an opinion of counsel) the Securities to its Affiliates (as defined
      below) provided that each such Affiliate is an “accredited investor” under
      Regulation D and such Affiliate agrees in writing to be bound by the terms
      and
      conditions of this Agreement. For the purposes of this Agreement, an
“Affiliate”
of
      any
      person or entity means any other person or entity directly or indirectly
      controlling, controlled by or under direct or indirect common control with
      such
      person or entity. Affiliate when employed in connection with the Company
      includes each Subsidiary [as defined in Section 5(a)] of the Company. For
      purposes of this definition, “control”
means
      the power to direct the management and policies of such person or firm, directly
      or indirectly, whether through the ownership of voting securities, by contract
      or otherwise.

     

    (h) 
Shares
      Legend.
      The
      Shares and the Warrant Shares shall bear the following or similar
      legend:

     

    “THE
      SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED. THESE SHARES MAY NOT BE SOLD, OFFERED FOR
      SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT UNDER SUCH SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAW
      OR AN
      OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE MEDICAL EXCHANGE INC. THAT
      SUCH REGISTRATION IS NOT REQUIRED.”

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    (i)   
      Warrants
      Legend.
      The
      Warrants shall bear the following or
      similar legend:

     

    “THIS
      WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT
      BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT
      AND
      THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,
      OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
      REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT OR ANY APPLICABLE
      STATE
      SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE MEDICAL
      EXCHANGE INC. THAT SUCH REGISTRATION IS NOT REQUIRED.”

    

    (j)
       
Note
      Legend.
      The
      Note shall bear the following legend:

     

    “THIS
      NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE AND THE
      COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED
      FOR
      SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT AS TO THIS NOTE UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO THE MEDICAL EXCHANGE INC. THAT SUCH REGISTRATION IS NOT
      REQUIRED.”

     

    (k) 
Communication
      of Offer.
      The
      offer to sell the Securities was directly communicated to the Subscriber by
      the
      Company. At no time was the Subscriber presented with or solicited by any
      leaflet, newspaper or magazine article, radio or television advertisement,
      or
      any other form of general advertising or solicited or invited to attend a
      promotional meeting otherwise than in connection and concurrently with such
      communicated offer.

     

    (l)               
      Authority;
      Enforceability.
      This
      Agreement and other agreements delivered together with this Agreement or in
      connection herewith have been duly authorized, executed and delivered by the
      Subscriber and are valid and binding agreements enforceable in accordance with
      their terms, subject to bankruptcy, insolvency, fraudulent transfer,
      reorganization, moratorium and similar laws of general applicability relating
      to
      or affecting creditors’ rights generally and to general principles of equity;
      and Subscriber has full corporate power and authority necessary to enter into
      this Agreement and such other agreements and to perform its obligations
      hereunder and under all other agreements entered into by the Subscriber relating
      hereto.

    

    (m) 
No
      Governmental Review.
      Each
      Subscriber understands that no United States federal or state agency or any
      other governmental or state agency has passed on or made recommendations or
      endorsement of the Securities or the suitability of the investment in the
      Securities nor have such authorities passed upon or endorsed the merits of
      the
      offering of the Securities.

    

    (n) 
Correctness
      of Representations.
      Each
      Subscriber represents as to such Subscriber that the foregoing representations
      and warranties are true and correct as of the date hereof and, unless a
      Subscriber otherwise notifies the Company prior to the Closing Date shall be
      true and correct as of the Closing Date.

    

    (o) 
Survival.
      The
      foregoing representations and warranties shall survive the Closing Date until
      three years after the Closing Date.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    5.           Company
      Representations and Warranties.
      The
      Company represents and warrants to and agrees with each Subscriber that except
      as set forth in the Reports or the Other Written Information and as otherwise
      qualified in the Transaction Documents:

     

    (a)     Due
      Incorporation.
      The
      Company is a corporation duly organized, validly existing and in good standing
      under the laws of the jurisdiction of its incorporation and has the requisite
      corporate power to own its properties and to carry on its business is disclosed
      in the Reports.
      The
      Company is duly qualified as a foreign corporation to do business and is in
      good
      standing in each jurisdiction where the nature of the business conducted or
      property owned by it makes such qualification necessary, other than those
      jurisdictions in which the failure to so qualify would not have a Material
      Adverse Effect. For purpose of this Agreement, a “Material
      Adverse Effect”
shall
      mean a material adverse effect on the financial condition, results of
      operations, properties or business of the Company taken individually, or in
      the
      aggregate, as a whole. For purposes of this Agreement, “Subsidiary”
means,
      with respect to any entity at any date, any corporation, limited or general
      partnership, limited liability company, trust, estate, association, joint
      venture or other business entity) of which more than 50% of (i) the
      outstanding capital stock having (in the absence of contingencies) ordinary
      voting power to elect a majority of the board of directors or other managing
      body of such entity, (ii) in the case of a partnership or limited liability
      company, the interest in the capital or profits of such partnership or limited
      liability company or (iii) in the case of a trust, estate, association,
      joint venture or other entity, the beneficial interest in such trust, estate,
      association or other entity business is, at the time of determination, owned
      or
      controlled directly or indirectly through one or more intermediaries, by such
      entity. As of the Closing Date, IDO Security, Ltd. will be a Subsidiary of
      the
      Company.

     

    (b)     Outstanding
      Stock.
      All
      issued and outstanding shares of capital stock of the Company have been duly
      authorized and validly issued and are fully paid and nonassessable.

     

    (c) 
Authority;
      Enforceability.
      This
      Agreement, the Note, the Warrants, the Escrow Agreement, Security Agreement,
      and
      Collateral Agent Agreement, and any other agreements delivered together with
      this Agreement or in connection herewith (collectively “Transaction
      Documents”)
      have
      been duly authorized, executed and delivered by the Company and are valid and
      binding agreements enforceable in accordance with their terms, subject to
      bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
      similar laws of general applicability relating to or affecting creditors’ rights
      generally and to general principles of equity. The Company has full corporate
      power and authority necessary to enter into and deliver the Transaction
      Documents and to perform its obligations thereunder.

     

    (d) 
Additional
      Issuances.
      There
      are no outstanding agreements or preemptive or similar rights affecting the
      Company’s Common Stock or other equity and no outstanding rights, warrants or
      options to acquire, or instruments convertible into or exchangeable for, or
      agreements or understandings with respect to the sale or issuance of any Common
      Stock or equity of the Company except as described on Schedule
      5(d).
      The
      Common Stock and all other equity of the Company on a fully diluted basis
      outstanding as of immediately following the Closing is set forth on Schedule
      5(d).

     

    (e) 
Consents.
      No
      consent, approval, authorization or order of any court, governmental agency
      or
      body or arbitrator having jurisdiction over the Company, or any of its
      Affiliates, any Principal Market (as defined in Section 9(b) of this Agreement),
      nor the Company’s shareholders is required for the execution by the Company of
      the Transaction Documents and compliance and performance by the Company of
      its
      obligations under the Transaction Documents, including, without limitation,
      the
      issuance and sale of the Securities.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (f)               
      No
      Violation or Conflict.
      Assuming the representations and warranties of the Subscribers in Section 4
      are
      true and correct, neither the issuance and sale of the Securities nor the
      performance of the Company’s obligations under this Agreement and all other
      agreements entered into by the Company relating thereto by the Company
      will:

     

    (i) 
violate,
      conflict with, result in a breach of, or constitute a default (or an event
      which
      with the giving of notice or the lapse of time or both would be reasonably
      likely to constitute a default in any material respect) under (A) the articles
      or certificate of incorporation, charter or bylaws of the Company, (B) to the
      Company’s knowledge, any decree, judgment, order, law, treaty, rule, regulation
      or determination applicable to the Company of any court, governmental agency
      or
      body, or arbitrator having jurisdiction over the Company or over the properties
      or assets of the Company or any of its Affiliates, (C) the terms of any bond,
      debenture, note or any other evidence of indebtedness, or any agreement, stock
      option or other similar plan, indenture, lease, mortgage, deed of trust or
      other
      instrument to which the Company or any of its Affiliates, by which the Company
      or any of its Affiliates is bound, or to which any of the properties of the
      Company or any of its Affiliates is subject, or (D) the terms of any “lock-up”
or similar provision of any underwriting or similar agreement to which the
      Company, or any of its Affiliates is a party except the violation, conflict,
      breach, or default of which would not have a Material Adverse Effect;
      or

     

    (ii)           
result
      in
      the creation or imposition of any lien, charge or encumbrance upon the
      Securities or any of the assets of the Company or any of its Affiliates;
      or

     

    (iii)           result
      in
      the activation of any anti-dilution rights or a reset or repricing of any debt
      or security instrument of any other creditor or equity holder of the Company,
      nor result in the acceleration of the due date of any obligation of the Company;
      or

     

    (iv)           result
      in
      the activation of any piggy-back registration rights of any person or entity
      holding securities or debt of the Company or having the right to receive
      securities of the Company.

     

    (g) 
The
      Securities.
      The
      Securities upon issuance:

     

    (i)            
      are,
      or
      will be, free and clear of any security interests, liens, claims or other
      encumbrances, subject to restrictions upon transfer under the 1933 Act and
      any
      applicable state securities laws;

    

    (ii)           
have
      been, or will be, duly and validly authorized and on the date of issuance of
      the
      Shares and upon exercise of the Warrants, the Shares and Warrant Shares will
      be
      duly and validly issued, fully paid and nonassessable and, if registered
      pursuant to the 1933 Act and resold pursuant to an effective registration
      statement, will be free trading and unrestricted;

     

    (iii)           will
      not
      have been issued or sold in violation of any preemptive or other similar rights
      of the holders of any securities of the Company;

     

    (iv)           will
      not
      subject the holders thereof to personal liability by reason of being such
      holders provided Subscriber’s representations herein are true and accurate and
      Subscribers take no actions or fail to take any actions required for their
      purchase of the Securities to be in compliance with all applicable laws and
      regulations; and

     

    (v)           will
      have
      been issued in reliance upon an exemption from the registration requirements
      of
      and will not result in a violation of Section 5 under the 1933 Act.

     

    (h) 
Litigation.
      There
      is no pending or, to the best knowledge of the Company, threatened action,
      suit,
      proceeding or investigation before any court, governmental agency or body,
      or
      arbitrator having jurisdiction over the Company, or any of its Affiliates that
      would affect the execution by the Company or the performance by the Company
      of
      its obligations under the Transaction Documents. There is no pending or, to
      the
      best knowledge of the Company, basis for or threatened action, suit, proceeding
      or investigation before any court, governmental agency or body, or arbitrator
      having jurisdiction over the Company, or any of its Affiliates which litigation
      if adversely determined would have a Material Adverse Effect.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    (i)               
      Reporting
      Company.
      The
      Company is a publicly-held company subject to reporting obligations pursuant
      to
      Section 13 of the Securities Exchange Act of 1934 (the “1934
      Act”)
      and
      has a
      class of common shares registered pursuant to Section 12(g) of the 1934 Act.
      Pursuant to the provisions of the 1934 Act, the Company has timely filed all
      reports and other materials required to be filed thereunder with the Commission
      during the preceding thirty-six months.

     

    (j)   
      No
      Market Manipulation.
      The
      Company and its Affiliates have not taken, and will not take, directly or
      indirectly, any action designed to, or that might reasonably be expected to,
      cause or result in stabilization or manipulation of the price of the Common
      Stock to
      facilitate the sale or resale of the Securities or affect the price at which
      the
      Securities may be issued or resold, provided, however, that this provision
      shall
      not prevent the Company from engaging in investor relations/public relations
      activities consistent with past practices.

     

    (k)             
       Information
      Concerning Company.
      The
      Reports contain all material information relating to the Company and its
      operations and financial condition as of their respective dates as required
      to
      be disclosed therein. Since the last day of the fiscal year of the most recent
      audited financial statements included in the Reports (“Latest
      Financial Date”),
      and
      except as modified in the Other Written Information or in the Schedules hereto,
      there has been no Material Adverse Event relating to the Company’s business,
      financial condition or affairs not disclosed in the Reports. The Reports
      including the financial statements therein, do not contain any untrue statement
      of a material fact or omit to state a material fact required to be stated
      therein or necessary to make the statements therein not misleading in light
      of
      the circumstances when made.

     

    (l)               
      Stop
      Transfer.
      The
      Company will not issue any stop transfer order or other order impeding the
      sale,
      resale or delivery of any of the Securities, except as may be required by any
      applicable federal or state securities laws and unless contemporaneous notice
      of
      such instruction is given to the Subscriber.

     

    (m) 
Defaults.
      The
      Company is not in violation of its articles of incorporation or bylaws. The
      Company is (i) not in default under or in violation of any other material
      agreement or instrument to which it is a party or by which it or any of its
      properties are bound or affected, which default or violation would have a
      Material Adverse Effect,
      (ii)
      not in default with respect to any order of any court, arbitrator or
      governmental body or subject to or party to any order of any court or
      governmental authority arising out of any action, suit or proceeding under
      any
      statute or other law respecting antitrust, monopoly, restraint of trade, unfair
      competition or similar matters, or (iii) to the Company’s knowledge not in
      violation of any statute, rule or regulation of any governmental authority
      which
      violation would have a Material Adverse Effect.

     

    (n) 
Not
      an
      Integrated Offering.
      Neither
      the Company, nor any of its Affiliates, nor any person acting on its or their
      behalf, has directly or indirectly made any offers or sales of any security
      or
      solicited any offers to buy any security under circumstances that would cause
      the offer of the Securities pursuant to this Agreement to be integrated with
      prior offerings by the Company for purposes of the 1933 Act or any applicable
      stockholder approval provisions, including, without limitation, under the rules
      and regulations of the OTC Bulletin Board (“Bulletin
      Board”)
      which
      would impair the exemptions relied upon in this Offering or the Company’s
      ability to timely comply with its obligations hereunder. Nor will the Company
      or
      any of its Affiliates take any action or steps that would cause the offer or
      issuance of the Securities to be integrated with other offerings which would
      impair the exemptions relied upon in this Offering or the Company’s ability to
      timely comply with its obligations hereunder. The Company will not conduct
      any
      offering other than the transactions contemplated hereby that will be integrated
      with the offer or issuance of the Securities, which would impair the exemptions
      relied upon in this Offering or the Company’s ability to timely comply with its
      obligations hereunder.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (o) 
No
      General Solicitation.
      Neither
      the Company, nor any of its Affiliates, nor to its knowledge, any person acting
      on its or their behalf, has engaged in any form of general solicitation or
      general advertising (within the meaning of Regulation D under the 1933 Act)
      in
      connection with the offer or sale of the Securities.

     

    (p) 
Listing.
      The
      Company’s common stock is quoted on the Bulletin Board under the symbol MXCH.OB.
      The Company has not received any oral or written notice that its common stock
      is
      not eligible nor will become ineligible for quotation on the Bulletin Board
      nor
      that its common stock does not meet all requirements for the continuation of
      such quotation. The Company satisfies all the requirements for the continued
      quotation of its common stock on the Bulletin Board.

     

    (q) 
No
      Undisclosed Liabilities.
      The
      Company has no liabilities or obligations which are material, individually
      or in
      the aggregate, which are not disclosed in the Reports and Other Written
      Information, other than those incurred in the ordinary course of the Company’s
      businesses since the Latest Financial Date and which, individually or in the
      aggregate, would reasonably be expected to have a Material Adverse
      Effect.

     

    (r)               
      No
      Undisclosed Events or Circumstances.
      Since
      the Latest Financial Date, no event or circumstance has occurred or exists
      with
      respect to the Company or its businesses, properties, operations or financial
      condition, that, under applicable law, rule or regulation, requires public
      disclosure or announcement prior to the date hereof by the Company but which
      has
      not been so publicly announced or disclosed in the Reports.

     

    (s)              
      Capitalization.
      The
      authorized and outstanding capital stock of the Company as of the date of this
      Agreement and the Closing Date (not including the Securities) are set forth
      on
Schedule
      5(d).
      Except
      as set forth on Schedule
      5(d),
      there
      are no options, warrants, or rights to subscribe to, securities, rights or
      obligations convertible into or exchangeable for or giving any right to
      subscribe for any shares of capital stock of the Company or any of its
      Subsidiaries. All of the outstanding shares of Common Stock of the Company
      have
      been duly and validly authorized and issued and are fully paid and
      nonassessable.

     

    (t)               
      Dilution.
      The
      Company’s executive officers and directors understand the nature of the
      Securities being sold hereby and recognize that the issuance of the Securities
      will have a potential dilutive effect on the equity holdings of other holders
      of
      the Company’s equity or rights to receive equity of the Company. The board of
      directors of the Company has concluded, in its good faith business judgment
      that
      the issuance of the Securities is in the best interests of the Company. The
      Company specifically acknowledges that its obligation to issue the Shares upon
      conversion of the Notes, and the Warrant Shares upon exercise of the Warrants
      is
      binding upon the Company and enforceable regardless of the dilution such
      issuance may have on the ownership interests of other shareholders of the
      Company or parties entitled to receive equity of the Company.

     

    (u)             
No
      Disagreements with Accountants and Lawyers.
      There
      are no disagreements of any kind presently existing, or reasonably anticipated
      by the Company to arise, between the Company and the accountants and lawyers
      formerly or presently employed by the Company, including but not limited to
      disputes or conflicts over payment owed to such accountants and lawyers and
      to
      their knowledge, nor have there been any such disagreements during the two
      years
      prior to the Closing Date.

    

    (v) 
Transfer
      Agent/DTC Status.
      The
      Company’s transfer agent is a participant in and the Common Stock is eligible
      for transfer pursuant to the Depository Trust Company Automated Securities
      Transfer Program. The name, address, telephone number, fax number, contact
      person and email address of the Company transfer agent is set forth on
Schedule
      5(v)
      hereto.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    (w) 
Investment
      Company.
      Neither
      the Company nor any Affiliate is an “investment company” within the meaning of
      the Investment Company Act of 1940, as amended.

    

    (x) 
Company
      Predecessor.
      All
      representations made by or relating to the Company of a historical or
      prospective nature and all undertakings described in Sections 9(g) through
      9(l)
      shall relate, apply and refer to the Company and its predecessors.

    

    (y) 
Correctness
      of Representations.
      The
      Company represents that the foregoing representations and warranties are true
      and correct as of the date hereof in all material respects, and, unless the
      Company otherwise notifies the Subscribers prior to the Closing Date, shall
      be
      true and correct in all material respects as of the Closing Date.

     

    (z) 
Survival.
      The
      foregoing representations and warranties shall survive until three years after
      the Closing Date.

     

    6. 
Regulation
      D Offering.
      The
      offer and issuance of the Securities to the Subscribers is being made pursuant
      to the exemption from the registration provisions of the 1933 Act afforded
      by
      Section 4(2) or Section 4(6) of the 1933 Act and/or Rule 506 of Regulation
      D
      promulgated thereunder. On the Closing Date, the Company will provide an opinion
      reasonably acceptable to Subscriber from the Company’s legal counsel opining on
      the availability of an exemption from registration under the 1933 Act as it
      relates to the offer and issuance of the Securities and other matters reasonably
      requested by Subscribers. A form of the legal opinion is annexed hereto as
      Exhibit
      F.
      The
      Company will provide, at the Company’s expense, such other legal opinions in the
      future as are reasonably necessary for the issuance and resale of the Common
      Stock issuable upon conversion of the Notes and exercise of the Warrants
      pursuant to an effective registration statement, Rule 144 under the 1933 Act
      or
      an exemption from registration.

    

    7.1. 
Conversion
      of Note.

    

    (a) 
Upon
      the
      conversion of a Note or part thereof, the Company shall, at its own cost and
      expense, take all necessary action, including obtaining and delivering, an
      opinion of counsel to assure that the Company’s transfer agent shall issue stock
      certificates in the name of Subscriber (or its permitted nominee) or such other
      persons as designated by Subscriber and in such denominations to be specified
      at
      conversion representing the number of shares of Common Stock issuable upon
      such
      conversion. The Company warrants that no instructions other than these
      instructions have been or will be given to the transfer agent of the Company’s
      Common Stock and that the certificates representing such shares shall contain
      no
      legend other than the usual 1933 Act restriction from transfer legend. If and
      when the Subscriber sells the Shares and Warrant Shares, assuming (i) the
      Registration Statement (as defined below) is effective and the prospectus,
      as
      supplemented or amended, contained therein is current and (ii) the Subscriber
      confirms in writing to the transfer agent that the Subscriber has complied
      with
      the prospectus delivery requirements, the restrictive legend can be removed
      and
      the Shares and Warrant Shares will be free-trading, and freely transferable.
      In
      the event that the Shares and Warrant Shares are sold in a manner that complies
      with an exemption from registration, the Company will promptly instruct its
      counsel to issue to the transfer agent an opinion permitting removal of the
      legend (indefinitely, if pursuant to Rule 144(k) of the 1933 Act, or for 90
      days
      if pursuant to the other provisions of Rule 144 of the 1933 Act). 

    

    (b) 
Subscriber
      will give notice of its decision to exercise its right to convert the Note,
      interest, any sum due to the Subscriber under the Transaction Documents or
      part
      thereof by telecopying an executed and completed Notice
      of Conversion
      (a form
      of which is annexed as Exhibit
      A
      to the
      Note) to the Company via confirmed telecopier transmission or otherwise pursuant
      to Section 13(a) of this Agreement. The Subscriber will not be
      required to surrender the Note
      until
      the Note has been fully converted or satisfied. Each date on which a Notice
      of
      Conversion is telecopied to the Company in accordance with the provisions hereof
      shall be deemed a Conversion
      Date.
      The
      Company will itself or cause the Company’s transfer agent to transmit the
      Company’s Common Stock certificates representing the Shares issuable upon
      conversion of the Note to the Subscriber via express courier for receipt by
      such
      Subscriber within three (3) business days after receipt by the Company of the
      Notice of Conversion (such third day being the “Delivery
      Date”).
      In
      the event the Shares are electronically transferable, then delivery of the
      Shares must
      be made
      by electronic transfer provided request for such electronic transfer has been
      made by the Subscriber
      and the Subscriber has complied with all applicable securities laws in
      connection with the sale of the Common Stock, including, without limitation,
      the
      prospectus delivery requirements. A Note representing the balance of the Note
      not so converted will be provided by the Company to the Subscriber if requested
      by Subscriber, provided the Subscriber delivers the
      original Note to the Company. In the event that a Subscriber elects not to
      surrender a Note for reissuance upon partial payment or conversion, the
      Subscriber hereby indemnifies the Company against any and all loss or damage
      attributable to a third-party claim in an amount in excess of the actual amount
      then due under the Note. “Business
      day”
and
      “trading
      day”
as
      employed in the Transaction Documents is a day that the New York Stock Exchange
      is open for trading for three or more hours.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    (c) 
The
      Company understands that a delay in the delivery of the Shares in the form
      required pursuant to Section 7.1 hereof, or the Mandatory Redemption Amount
      described in Section 7.2 hereof, respectively after the Delivery Date or the
      Mandatory Redemption Payment Date (as hereinafter defined) could result in
      economic loss to the Subscriber. As compensation to the Subscriber for such
      loss, the Company agrees to pay (as liquidated damages and not as a penalty)
      to
      the Subscriber for late issuance of Shares in the form required pursuant to
      Section 7.1 hereof upon Conversion of the Note in the amount of $100 per
      business day after the Delivery Date for each $10,000 of Note principal amount
      being converted of the corresponding Shares which are not timely delivered.
      The
      Company shall pay any payments incurred under this Section in immediately
      available funds upon demand. Furthermore, in addition to any other remedies
      which may be available to the Subscriber, in the event that the Company fails
      for any reason to effect delivery of the Shares by the Delivery Date or make
      payment by the Mandatory Redemption Payment Date, the Subscriber may revoke
      all
      or part of the relevant Notice of Conversion or rescind all or part of the
      notice of Mandatory Redemption by delivery of a notice to such effect to the
      Company whereupon the Company and the Subscriber shall each be restored to
      their
      respective positions immediately prior to the delivery of such notice, except
      that the liquidated damages described above shall be payable through the date
      notice of revocation or rescission is given to the Company.

    

    (d) 
Nothing
      contained herein or in any document referred to herein or delivered in
      connection herewith shall be deemed to establish or require the payment of
      a
      rate of interest or other charges in excess of the maximum permitted by
      applicable law. In the event that the rate of interest or dividends required
      to
      be paid or other charges hereunder exceed the maximum permitted by such law,
      any
      payments in excess of such maximum shall be credited against amounts owed by
      the
      Company to the Subscriber and thus refunded to the Company.

    

    7.2.        Mandatory
      Redemption at Subscriber’s Election.
      In the
      event (i) the Company is prohibited from issuing Shares, (ii) the Company fails
      to timely deliver Shares on a Delivery Date, (iii) upon the occurrence of any
      other Event of Default (as defined in the Note or in this Agreement), any of
      the
      foregoing that continues for more than twenty (20) business days, (iv) a Change
      in Control (as defined below), or (v) of the liquidation, dissolution or winding
      up of the Company, then at the Subscriber’s election, the Company must pay to
      the Subscriber ten (10) business days after request by the Subscriber
      (“Calculation
      Period”),
      a sum
      of money determined by multiplying up to the outstanding principal amount of
      the
      Note designated by the Subscriber by 120%, together with accrued but unpaid
      interest thereon (“Mandatory
      Redemption Payment”).
      The
      Mandatory Redemption Payment must be received by the Subscriber on the same
      date
      as the Shares otherwise deliverable or within ten (10) business days after
      request, whichever is sooner (“Mandatory
      Redemption Payment Date”).
      Upon
      receipt of the Mandatory Redemption Payment, the corresponding Note principal
      and interest will be deemed paid and no longer outstanding. Liquidated damages
      calculated pursuant to Section 7.1(c) hereof, that have been paid or accrued
      for
      the ten day period prior to the actual receipt of the Mandatory Redemption
      Payment by the Subscriber shall be credited against the Mandatory Redemption
      Payment. For purposes of this Section 7.2, “Change
      in Control”
shall
      mean (i) the Company no longer having a class of shares publicly traded or
      listed on a Principal Market, (ii) the Company becoming a Subsidiary of another
      entity (other than a corporation formed by the Company for purposes of
      reincorporation in another U.S. jurisdiction or which is publicly traded and
      which as part of the agreement with such corporation agrees to issue tradeble
      shares upon conversion of the Note or exercise of the Warrant), except in
      connection with the acquisition of IDO Security Ltd., (iii) a majority of the
      board of directors of the Company as of the Closing Date no longer serving
      as
      directors of the Company except due to natural causes, (iv) the sale, lease
      or
      transfer of substantially all the assets of the Company or Subsidiaries, or
      (v)
      if the holders of the Company’s Common Stock as of the Closing Date beneficially
      own at any time after the Closing Date less than forty percent of the Common
      Stock owned by them on the Closing Date. 

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    7.3.       
      Maximum
      Conversion.
      The
      Subscriber shall not be entitled to convert on a Conversion Date that amount
      of
      the Note in connection with that number of shares of Common Stock which would
      be
      in excess of the sum of (i) the number of shares of common stock beneficially
      owned by the Subscriber and its Affiliates on a Conversion Date, and (ii) the
      number of shares of Common Stock issuable upon the conversion of the Note with
      respect to which the determination of this provision is being made on a
      Conversion Date, which would result in beneficial ownership by the Subscriber
      and its Affiliates of more than 4.99% of the outstanding shares of common stock
      of the Company on such Conversion Date. Beneficial ownership shall be determined
      in accordance with Section 13(d) of the Securities Exchange Act of 1934, as
      amended, and Regulation 13d-3 thereunder. Subject to the foregoing, the
      Subscriber shall be limited to aggregate conversions of only 4.99%. The
      Subscriber may decide whether to convert a Note or exercise Warrants to achieve
      an actual 4.99% ownership position as described above.

    

    7.4.        Injunction
      Posting of Bond.
      In the
      event a Subscriber shall elect to convert a Note or part thereof or exercise
      the
      Warrant in whole or in part, the Company may not refuse conversion or exercise
      based on any claim that such Subscriber or any one associated or affiliated
      with
      such Subscriber has been engaged in any violation of law, or for any other
      reason, unless, an injunction from a court, on notice, restraining and or
      enjoining conversion of all or part of such Note or exercise of all or part
      of
      such Warrant shall have been sought and obtained by the Company
      or at
      the Company’s request or with the Company’s assistance, and
      the
      Company has posted a surety bond for the benefit of such Subscriber in the
      amount of 120% of the outstanding principal and interest of the Note, or
      aggregate purchase price of the Shares and Warrant Shares which are sought
      to be
      subject to the injunction, which bond shall remain in effect until the
      completion of arbitration/litigation of the dispute and the proceeds of which
      shall be payable to such Subscriber to the extent Subscriber obtains judgment
      in
      Subscriber’s favor.

    

    7.5.        Buy-In.
      In
      addition to any other rights available to the Subscriber, if the Company fails
      to deliver to the Subscriber such shares issuable upon conversion of a Note
      by
      the Delivery Date and if after seven (7) business days after the Delivery Date
      the Subscriber or a broker on the Subscriber’s behalf, purchases (in an open
      market transaction or otherwise) shares of Common Stock to deliver in
      satisfaction of a sale by such Subscriber of the Common Stock which the
      Subscriber was entitled to receive upon such conversion (a “Buy-In”),
      then
      the Company shall pay in cash to the Subscriber (in addition to any remedies
      available to or elected by the Subscriber) the amount by which (A) the
      Subscriber’s total purchase price (including brokerage commissions, if any) for
      the shares of Common Stock so purchased exceeds (B) the aggregate principal
      and/or interest amount of the Note for which such conversion was not timely
      honored,
      together with interest thereon at a rate of 15% per annum, accruing until such
      amount and any accrued interest thereon is paid in full (which amount shall
      be
      paid as liquidated damages and not as a penalty). For
      example, if the Subscriber purchases shares of Common Stock having a total
      purchase price of $11,000 to cover a Buy-In with respect to an attempted
      conversion of $10,000 of note principal and/or interest, the Company shall
      be
      required to pay the Subscriber $1,000,
      plus interest. The
      Subscriber shall provide the Company written notice indicating the amounts
      payable to the Subscriber in respect of the Buy-In.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    7.6.        Adjustments.
      The
      Conversion Price, Warrant exercise price and amount of Shares issuable upon
      conversion of the Notes and exercise of the Warrants shall be adjusted as
      described in this Agreement, the Notes and Warrants.

     

    7.7.       
      Redemption.
      The
      Note and Warrants shall not be redeemable or mandatorily convertible except
      as
      described in the Note and Warrants. 

    

    8.           Due
      Diligence Fee/Legal Fees.

    

    (a)  
Due
      Diligence Fee/Incentive Shares.
      The
      Company on the one hand, and each Subscriber (for himself only) on the other
      hand, agrees to indemnify the other against and hold the other harmless from
      any
      and all liabilities to any persons claiming Due Diligence Fee or Incentive
      Shares other than the one or more entities identified on Schedule
      8
      hereto
      on account of services purported to have been rendered on behalf of the
      indemnifying party in connection with this Agreement or the transactions
      contemplated hereby and arising out of such party’s actions. Anything in this
      Agreement to the contrary notwithstanding, each Subscriber is providing
      indemnification only for such Subscriber’s own actions and not for any action of
      any other Subscriber. Each Subscriber’s liability hereunder is several and not
      joint. The Company agrees that it will pay the fees set forth on Schedule
      8
      hereto
      (“Due
      Diligence Fees”)
      and
      issue the Incentive Shares as set forth on Schedule
      8
      hereto
      (“Incentive
      Shares”).
      The
      Company represents that there are no other parties entitled to receive fees,
      commissions, or similar payments in connection with the offering described
      in
      this Agreement.

     

    (b)  
Legal
      Fees.
      The
      Company shall pay to Grushko & Mittman, P.C., a cash fee of $2,500
      (“Legal
      Fees”)
      as
      reimbursement for services rendered to the Subscribers in connection with this
      Agreement and the purchase and sale of the Notes and Warrants (the “Offering”).
      The
      Legal Fees and reimbursement for estimated UCC searches and filing fees (less
      any amounts paid prior to a Closing Date), and estimated printing and shipping
      costs for the closing statements to be delivered to Subscribers, will be payable
      on the second Closing Date out of funds held pursuant to the Escrow
      Agreement.

     

    9. 
Covenants
      of the Company.
      The
      Company covenants and agrees with the Subscribers as follows:

     

    (a) 
Stop
      Orders.
      The
      Company will advise the Subscribers, within two hours after the Company receives
      notice of issuance by the Commission, any state securities commission or any
      other regulatory authority of any stop order or of any order preventing or
      suspending any offering of any securities of the Company, or of the suspension
      of the qualification of the Common Stock of the Company for offering or sale
      in
      any jurisdiction, or the initiation of any proceeding for any such
      purpose.

     

    (b) 
Listing.
      The
      Company shall promptly secure the listing of the shares of Common Stock and
      the
      Warrant Shares upon each national securities exchange, or electronic or
      automated quotation system upon which they are or become eligible for listing
      and shall maintain such listing so long as any Notes or Warrants are
      outstanding. The Company will maintain the listing or quotation of its Common
      Stock on the American Stock Exchange, Nasdaq Capital Market, Nasdaq National
      Market System, Bulletin Board, or New York Stock Exchange (whichever of the
      foregoing is at the time the principal trading exchange or market for the Common
      Stock (the “Principal
      Market”),
      and
      will comply in all respects with the Company’s reporting, filing and other
      obligations under the bylaws or rules of the Principal Market, as applicable.
      The Company will provide the Subscribers copies of all notices it receives
      notifying the Company of the threatened and actual delisting of the Common
      Stock
      from any Principal Market. As of the date of this Agreement, the Bulletin Board
      is the Principal Market.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (c) 
Market
      Regulations.
      The
      Company shall notify the Commission, the Principal Market and applicable state
      authorities, in accordance with their requirements, of the transactions
      contemplated by this Agreement, and shall take all other necessary action and
      proceedings as may be required and permitted by applicable law, rule and
      regulation, for the legal and valid issuance of the Securities to the
      Subscribers and promptly provide copies thereof to Subscriber.

     

    (d) 
Filing
      Requirements.
      From
      the date of this Agreement and until the sooner of (i) two (2) years after
      the
      Closing Date, or (ii) until all the Shares and Warrant Shares have been resold
      or transferred by all the Subscribers pursuant to the Registration Statement
      or
      pursuant to Rule 144, without regard to volume limitations, the Company will
      (A)
      cause its Common Stock to continue to be registered under Section 12(b) or
      12(g)
      of the 1934 Act, (B) comply in all respects with its reporting and filing
      obligations under the 1934 Act, (C) voluntarily comply with all reporting
      requirements that are applicable to an issuer with a class of shares registered
      pursuant to Section 12(g) of the 1934 Act, if Company is not subject to such
      reporting requirements, and (D) comply with all requirements related to any
      registration statement filed pursuant to this Agreement. The Company will use
      its best efforts not to take any action or file any document (whether or not
      permitted by the 1933 Act or the 1934 Act or the rules thereunder) to terminate
      or suspend such registration or to terminate or suspend its reporting and filing
      obligations under said acts until two (2) years after the Closing Date. Until
      the earlier of the resale of the Shares and the Warrant Shares by each
      Subscriber or two (2) years after the Closing Date, the Company will use its
      best efforts to continue the listing or quotation of the Common Stock on a
      Principal Market and will comply in all respects with the Company’s reporting,
      filing and other obligations under the bylaws or rules of the Principal Market.
      The Company agrees to timely file a Form D with respect to the Securities if
      required under Regulation D and to provide a copy thereof to each Subscriber
      promptly after such filing.

     

    (e) 
Use
      of
      Proceeds.
      The
      proceeds of the Offering will be employed by the Company for the purposes set
      forth on Schedule
      9(e)
      hereto.
      Except as set forth on Schedule
      9(e),
      the
      Purchase Price may not and will not be used for accrued and unpaid officer
      and
      director salaries, payment of financing related debt, redemption of outstanding
      notes or equity instruments of the Company, litigation related expenses or
      settlements, brokerage fees, nor non-trade obligations outstanding on a Closing
      Date.

     

    (f) 
Reservation.
      Prior
      to the Closing Date, the Company undertakes to reserve, pro rata,
      on
      behalf of the Subscribers from its authorized but unissued common stock, a
      number of common shares equal to 200%
      of
      the amount of Common Stock necessary to allow each Subscriber to be able to
      convert all Notes issuable pursuant to this Agreement and interest thereon
      and
      reserve 100% of the amount of Warrant Shares issuable upon exercise of the
      Warrants. Failure to have sufficient shares reserved pursuant to this Section
      9(f) shall be a material default of the Company’s obligations under this
      Agreement and an Event of Default under the Note.

     

    (g) 
Taxes.
      From
      the date of this Agreement and until the conversion or satisfaction of the
      Note,
      in its entirety, and exercise of the Warrants, the Company will promptly pay
      and
      discharge, or cause to be paid and discharged, when due and payable, all lawful
      taxes, assessments and governmental charges or levies imposed upon the income,
      profits, property or business of the Company; provided, however, that any such
      tax, assessment, charge or levy need not be paid if the validity thereof shall
      currently be contested in good faith by appropriate proceedings and if the
      Company shall have set aside on its books adequate reserves with respect
      thereto, and provided, further, that the Company will pay all such taxes,
      assessments, charges or levies forthwith upon the commencement of proceedings
      to
      foreclose any lien which may have attached as security therefore.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    (h) 
Insurance.
      From
      the date of this Agreement and until the conversion or satisfaction of the
      Note,
      in its entirety, and exercise of the Warrants, the Company will keep its assets
      which are of an insurable character insured by financially sound and reputable
      insurers against loss or damage by fire, explosion and other risks customarily
      insured against by companies in the Company’s line of business, in amounts
      sufficient to prevent the Company from becoming a co-insurer and not in any
      event less than one hundred percent (100%) of the insurable value of the
      property insured less reasonable deductible amounts; and the Company will
      maintain, with financially sound and reputable insurers, insurance against
      other
      hazards and risks and liability to persons and property to the extent and in
      the
      manner customary for companies in similar businesses similarly situated and
      to
      the extent available on commercially reasonable terms.

     

    (i)               
      Books
      and Records.
      From the
      date of this Agreement and until the conversion or satisfaction of the Note,
      in
      its entirety, and exercise of the Warrants, the Company will keep true records
      and books of account in which full, true and correct entries will be made of
      all
      dealings or transactions in relation to its business and affairs in accordance
      with generally accepted accounting principles applied on a consistent
      basis.

     

    (j)               
      Governmental
      Authorities.
      From the
      date of this Agreement and until the conversion or satisfaction of the Note,
      in
      its entirety, and exercise of the Warrants, the Company shall duly observe
      and
      conform in all material respects to all valid requirements of governmental
      authorities relating to the conduct of its business or to its properties or
      assets.

     

    (k) 
Intellectual
      Property.
      From
      the date of this Agreement and until the conversion or satisfaction of the
      Note,
      in its entirety, and exercise of the Warrants, the Company shall maintain in
      full force and effect its corporate existence, rights and franchises and all
      licenses and other rights to use intellectual property owned or possessed by
      it
      and reasonably deemed to be necessary to the conduct of its business, unless
      it
      is sold for value.

     

    (l)               
      Properties.
      From the
      date of this Agreement and until the conversion or satisfaction of the Note,
      in
      its entirety, and exercise of the Warrants, the Company will keep its properties
      in good repair, working order and condition, reasonable wear and tear excepted,
      and from time to time make all necessary and proper repairs, renewals,
      replacements, additions and improvements thereto; and the Company will at all
      times comply with each provision of all leases to which it is a party or under
      which it occupies property if the breach of such provision could reasonably
      be
      expected to have a Material Adverse Effect.

     

    (m) 
Confidentiality/Public
      Announcement.
      From the
      date of this Agreement and until the sooner of (i) two (2) years after the
      Closing Date, or (ii) until all the Shares and Warrant Shares have been resold
      or transferred by all the Subscribers pursuant to the Registration Statement
      or
      pursuant to Rule 144, without regard to volume limitations, the Company agrees
      that except in connection with a Form 8-K or the Registration Statement or
      as
      otherwise required in any other Commission filing, it will not disclose publicly
      or privately the identity of the Subscribers unless expressly agreed to in
      writing by a Subscriber, only to the extent required by law and then only upon
      five days prior notice to Subscriber. In any event and subject to the foregoing,
      the Company shall file
      a
      Form 8-K or make a public announcement describing the Offering not later than
      the first business day after the Closing Date. In the Form 8-K or public
      announcement, the Company will specifically disclose the amount of common stock
      outstanding immediately after the Closing. A form of the proposed Form 8-K
      or
      public announcement to be employed in connection with the Closing is annexed
      hereto as Exhibit
      G.

     

    (n) 
Further
      Registration Statements.
      Except
      for a registration statement filed on behalf of the Subscribers pursuant to
      Section 11 of this Agreement or as described on Schedule
      11.1
      hereto,
      the Company will not file with the Commission or with state regulatory
      authorities, any registration statements including but not limited to Forms
      S-8,
      or amend any already filed registration statement to increase the amount of
      Common Stock registered therein, or reduce the price of which such Common Stock
      is registered therein without the consent of the Subscriber until the expiration
      of the “Exclusion
      Period”,
      which
      shall be defined as the first to occur of (i) the Registration Statement having
      been current and available for use in connection with the resale of all of
      the
      Registrable Securities (as defined in Section 11.1(i) for a period of 180 days,
      or (ii) until all the Shares and Warrant Shares have been resold or transferred
      by the Subscribers pursuant to the Registration Statement or Rule 144, without
      regard to volume limitations, or (iii) the satisfaction of the Notes. The
      Exclusion Period will be tolled during the pendency of an Event of Default
      as
      defined in the Note.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    (o) 
Blackout.
      The
      Company undertakes and covenants that until the end of the Exclusion Period,
      the
      Company will not enter into any acquisition, merger, exchange or sale or other
      transaction that could have the effect of delaying the effectiveness of any
      pending Registration Statement or causing an already effective Registration
      Statement to no longer be effective or current for a period of twenty (20)
      or
      more days in the aggregate.

     

    (p) 
Non-Public
      Information.
      The
      Company covenants and agrees that neither it nor any other person acting on
      its
      behalf will provide any Subscriber or its agents or counsel with any information
      that the Company believes constitutes material non-public information, unless
      prior thereto such Subscriber shall have agreed in writing to receive such
      information. The Company understands and confirms that each Subscriber shall
      be
      relying on the foregoing representations in effecting transactions in securities
      of the Company. The Company will offer to the Subscriber an opportunity to
      review and comment on the Registration Statement thereto between three and
      five
      business days prior to the proposed filing date thereof.

     

    (q) 
Offering
      Restrictions.
      Until
      the expiration of the Exclusion Period and during the pendency of an Event
      of
      Default, except for the Excepted Issuances [as defined in Section 12(a)], the
      Company will not enter into an agreement to nor issue any equity, convertible
      debt or other securities convertible into common stock or equity of the Company
      nor modify any of the foregoing which may be outstanding at anytime, without
      the
      prior written consent of the Subscriber, which consent may be withheld for
      any
      reason. For so long as the Notes are outstanding, except for the Excepted
      Issuances, the Company will not enter into any equity line of credit or similar
      agreement, nor issue nor agree to issue any floating or variable priced equity
      linked instruments nor any of the foregoing or equity with price reset rights.
      The
      only
      officer, director, employee and consultant stock option or stock incentive
      plan
      currently in effect or contemplated by the Company has been submitted to the
      Subscribers. No other plan will be adopted nor may any options or equity not
      included in such plan be issued for so long as any sum is outstanding under
      the
      Note.

    

    (r) 
Additional
      Negative Covenants.
      So long
      as the Notes are outstanding and during the pendency of an Event of Default
      (as
      defined in the Note), without the consent of the Subscribers, the Company will
      not and will not permit any of its Subsidiaries to directly or
      indirectly:

    

    (i) 
create,
      incur, assume or suffer to exist any pledge, hypothecation, assignment, deposit
      arrangement, lien, charge, claim, security interest, security title, mortgage,
      security deed or deed of trust, easement or encumbrance, or preference, priority
      or other security agreement or preferential arrangement of any kind or nature
      whatsoever (including any lease or title retention agreement, any financing
      lease having substantially the same economic effect as any of the foregoing,
      and
      the filing of, or agreement to give, any financing statement perfecting a
      security interest under the Uniform Commercial Code or comparable law of any
      jurisdiction) (each, a “Lien”)
      upon
      any of its property, whether now owned or hereafter acquired except for (i)
      the
      Excepted Issuances, (ii) (a) Liens imposed by law for taxes that are not yet
      due
      or are being contested in good faith and for which adequate reserves have been
      established in accordance with generally accepted accounting principles; (b)
      carriers’, warehousemen’s, mechanics’, material men’s, repairmen’s and other
      like Liens imposed by law, arising in the ordinary course of business and
      securing obligations that are not overdue by more than 30 days or that are
      being
      contested in good faith and by appropriate proceedings; (c) pledges and deposits
      made in the ordinary course of business in compliance with workers’
compensation, unemployment insurance and other social security laws or
      regulations; (d) deposits to secure the performance of bids, trade contracts,
      leases, statutory obligations, surety and appeal bonds, performance bonds and
      other obligations of a like nature, in each case in the ordinary course of
      business; (e) Liens created with respect to the financing of the purchase of
      new
      property in the ordinary course of the Company’s business up to the amount of
      the purchase price of such property, or (f) easements, zoning restrictions,
      rights-of-way and similar encumbrances on real property imposed by law or
      arising in the ordinary course of business that do not secure any monetary
      obligations and do not materially detract from the value of the affected
      property (each of (a) through (f), a “Permitted
      Lien”)
      and
      (iii) indebtedness for borrowed money which is not senior or pari passu in
      right
      of payment to the payment of the Notes;

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

                                                                  
      (ii)            
amend
      its
      certificate of incorporation, bylaws or its charter documents so as to adversely
      affect any rights of the Subscriber;

     

                                                                 
      (iii)            repay,
      repurchase or offer to repay, repurchase or otherwise acquire or make any
      dividend or distribution in respect of any of its Common Stock, preferred stock,
      or other equity securities other than to the extent permitted or required under
      the Transaction Documents;

     

                                                 
      (iv)         prepay
      any financing related or other outstanding debt obligations except as described
      in Schedules
      9(e) and 9(r)(iv)
      or to
      suppliers in the ordinary course of business; or

     

                                  
      (v)           
engage
      in
      any transactions with any officer, director, employee or any Affiliate of the
      Company, including any contract, agreement or other arrangement providing for
      the furnishing of services to or by, providing for rental of real or personal
      property to or from, or otherwise requiring payments to or from any officer,
      director or such employee or, to the knowledge of the Company, any entity in
      which any officer, director, or any such employee has a substantial interest
      or
      is an officer, director, trustee or partner, in each case in excess of $10,000
      other than (i) for payment of salary or consulting fees for services rendered,
      (ii) reimbursement for expenses incurred on behalf of the Company and (iii)
      for
      other employee benefits, including stock option agreements under any stock
      option plan of the Company.

     

    10.          Covenants
      of the Company and Subscriber Regarding Indemnification.

     

    (a)              
      The
      Company agrees to indemnify, hold harmless, reimburse and defend the
      Subscribers, the Subscribers’ officers, directors, agents, Affiliates, control
      persons, and principal shareholders, against any claim, cost, expense,
      liability, obligation, loss or damage (including reasonable legal fees) of
      any
      nature, incurred by or imposed upon the Subscriber or any such person which
      results, arises out of or is based upon (i) any material misrepresentation
      by
      Company or material breach of any warranty by Company in this Agreement or
      in
      any Exhibits or Schedules attached hereto, or other agreement delivered pursuant
      hereto; or (ii) after any applicable notice and/or cure periods, any material
      breach or default in performance by the Company of any covenant or undertaking
      to be performed by the Company hereunder, or any other agreement entered into
      by
      the Company and Subscriber relating hereto.

     

    (b) 
Each
      Subscriber agrees to indemnify, hold harmless, reimburse and defend the Company
      and each of the Company’s officers, directors, agents, Affiliates, control
      persons against any claim, cost, expense, liability, obligation, loss or damage
      (including reasonable legal fees) of any nature, incurred by or imposed upon
      the
      Company or any such person which results, arises out of or is based upon (i)
      any
      material misrepresentation by such Subscriber in this Agreement or in any
      Exhibits or Schedules attached hereto, or other agreement delivered pursuant
      hereto; or (ii) after any applicable notice and/or cure periods, any material
      breach or default in performance by such Subscriber of any covenant or
      undertaking to be performed by such Subscriber hereunder, or any other agreement
      entered into by the Company and Subscribers, relating hereto.

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

     

    (c) 
In
      no
      event shall the liability of any Subscriber or permitted successor hereunder
      or
      under any Transaction Document or other agreement delivered in connection
      herewith be greater in amount than the dollar amount of the net proceeds
      actually received by such Subscriber upon the sale of Registrable Securities
      (as
      defined herein).

     

    (d) 
The
      procedures set forth in Section 11.6 shall apply to the indemnification set
      forth in Sections 10(a) and 10(b) above.

     

    11.1.       Registration
      Rights.
      The
      Company hereby grants the following registration rights to holders of the
      Securities.

     

    (i)               
      On
      one
      occasion, for a period commencing one hundred and twenty-one (121) days after
      the occurrence of an Event of Default (as defined in the Note), but not later
      than two (2) years after the Closing Date, upon a written request therefor
      from
      any record holder or holders of more than 50% of the Shares issued and issuable
      upon conversion of the outstanding Notes, outstanding Warrant Shares and Due
      Diligence Shares, the Company shall prepare and file with the Commission a
      registration statement under the 1933 Act registering the Registrable
      Securities, as defined in Section 11.1(iv) hereof, which are the subject of
      such
      request for unrestricted public resale by the holder thereof. For purposes
      of
      Sections 11.1(i) and 11.1(ii), Registrable Securities shall not include
      Securities which are (A) registered for resale in an effective registration
      statement, (B) included for registration in a pending registration statement,
      or
      (C) which have been issued without further transfer restrictions after a sale
      or
      transfer pursuant to Rule 144 under the 1933 Act. Upon the receipt of such
      request, the Company shall promptly give written notice to all other record
      holders of the Registrable Securities that such registration statement is to
      be
      filed and shall include in such registration statement Registrable Securities
      for which it has received written requests within ten (10) days after the
      Company gives such written notice. Such other requesting record holders shall
      be
      deemed to have exercised their demand registration right under this Section
      11.1(i).

     

    (ii) 
If
      the
      Company at any time proposes to register any of its securities under the 1933
      Act for sale to the public, whether for its own account or for the account
      of
      other security holders or both, except with respect to registration statements
      on Forms S-4, S-8 or another form not available for registering the Registrable
      Securities for sale to the public, provided the Registrable Securities are
      not
      otherwise registered for resale by the Subscribers or Holder pursuant to an
      effective registration statement, each such time it will give at least fifteen
      (15) days’ prior written notice to the record holder of the Registrable
      Securities of its intention so to do. Upon the written request of the holder,
      received by the Company within ten (10) days after the giving of any such notice
      by the Company, to register any of the Registrable Securities not previously
      registered, the Company will cause such Registrable Securities as to which
      registration shall have been so requested to be included with the securities
      to
      be covered by the registration statement proposed to be filed by the Company,
      all to the extent required to permit the sale or other disposition of the
      Registrable Securities so registered by the holder of such Registrable
      Securities (the “Seller”
or
      “Sellers”).
      In
      the event that any registration pursuant to this Section 11.1(i) shall be,
      in
      whole or in part, an underwritten public offering of common stock of the
      Company, the number of shares of Registrable Securities to be included in such
      an underwriting may be reduced by the managing underwriter if and to the extent
      that the Company and the underwriter shall reasonably be of the opinion that
      such inclusion would adversely affect the marketing of the securities to be
      sold
      by the Company therein; provided, however, that the Company shall notify the
      Seller in writing of any such reduction. Notwithstanding the foregoing
      provisions, or Section 11.4 hereof, the Company may withdraw or delay or suffer
      a delay of any registration statement referred to in this Section 11.1(i)
      without thereby incurring any liability to the Seller.

     

    (iii) 
If,
      at
      the time any written request for registration is received by the Company
      pursuant to Section 11.1(i), the Company has determined to proceed with the
      actual preparation and filing of a registration statement under the 1933 Act
      in
      connection with the proposed offer and sale for cash of any of its securities
      for the Company’s own account and the Company actually does file such other
      registration statement, such written request shall be deemed to have been given
      pursuant to Section 11.1(ii) rather than Section 11.1(i), and the rights of
      the
      holders of Registrable Securities covered by such written request shall be
      governed by Section 11.1(ii).

     

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

    

     

    (iv) 
The
      Company shall file with the Commission a Form SB-2 registration statement (the
      “Registration
      Statement”)
      (or
      such other form that it is eligible to use) in order to register the Registrable
      Securities for resale and distribution under the 1933 Act within forty-five
      (45)
      calendar days after the occurrence of an Event of Default (the
      “Filing
      Date”),
      and
      cause the Registration Statement to be declared effective not
      later
      than one hundred and twenty (120) calendar days after the occurrence of an
      Event
      of Default (the
      “Effective
      Date”).
      The
      Company will register not less than a number of shares of common stock in the
      aforedescribed registration statement that is equal to 200%
      of
      the Shares issuable upon conversion of all of the Notes issuable to the
      Subscribers, and 100% of the Warrant Shares issuable upon exercise of the
      Warrants and any restricted shares issuable pursuant to Section 1.4 of the
      Note
      (collectively the “Registrable
      Securities”).
      The
      Registrable Securities shall be reserved and set aside exclusively for the
      benefit of each Subscriber and Warrant holder, pro rata,
      and not
      issued, employed or reserved for anyone other than each such Subscriber and
      Warrant holder. The Registration Statement will immediately be amended or
      additional registration statements will be immediately filed by the Company
      as
      necessary to register additional shares of Common Stock to allow the public
      resale of all Common Stock included in and issuable by virtue of the Registrable
      Securities. Except with the written consent of the Subscriber, no securities
      of
      the Company other than the Registrable Securities will be included in the
      Registration Statement. It shall be deemed a Non-Registration Event if at any
      time after the date the Registration Statement is declared effective by the
      Commission (“Actual
      Effective Date”)
      the
      Company has registered for unrestricted resale on behalf of the Subscribers
      fewer than 150%
      of
      the amount of Common Shares issuable upon full conversion of all sums due under
      the Notes and 100% of the Warrant Shares issuable upon exercise of the
      Warrants.

     

    11.2.         Registration
      Procedures.
      If and
      whenever the Company is required by the provisions of Section 11.1(i), 11.1(ii)
      or 11.1(iv) to effect the registration of any Registrable Securities under
      the
      1933 Act, the Company will, as expeditiously as possible: 

     

    (a) 
subject
      to the timelines provided in this Agreement, prepare and file with the
      Commission a registration statement required by Section 11, with respect to
      such
      securities and use its best efforts to cause such registration statement to
      become and remain effective for the period of the distribution contemplated
      thereby (determined as herein provided), promptly provide to the holders of
      the
      Registrable Securities copies of all filings and Commission letters of comment
      and notify Subscribers (by telecopier and by e-mail addresses provided by
      Subscribers) and Grushko & Mittman, P.C. (by telecopier and by email to
Counslers@aol.com)
      on or
      before 6:00 PM EST on the same business day that the Company receives notice
      that (i) the Commission has no comments or no further comments on the
      Registration Statement, and (ii) the registration statement has been declared
      effective (failure to timely provide notice as required by this Section 11.2(a)
      shall be a material breach of the Company’s obligation and an Event of Default
      as defined in the Notes
      and
      a Non-Registration Event as defined in Section 11.4 of this Agreement);

     

    (b)            
       prepare
      and file with the Commission such amendments and supplements to such
      registration statement and the prospectus used in connection therewith as may
      be
      necessary to keep such registration statement effective until such registration
      statement has been effective for a period of two (2) years, and comply with
      the
      provisions of the 1933 Act with respect to the disposition of all of the
      Registrable Securities covered by such registration statement in accordance
      with
      the Sellers’ intended method of disposition set forth in such registration
      statement for such period; 

     

    (c) 
furnish
      to the Sellers, at the Company’s expense, such number of copies of the
      registration statement and the prospectus included therein (including each
      preliminary prospectus) as such persons reasonably may request in order to
      facilitate the public sale or their disposition of the securities covered by
      such registration statement or make them electronically available; 

     

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

     

    (d) 
use
      its
commercially
      reasonable best efforts to register or qualify the Registrable Securities
      covered by such registration statement under the securities or “blue sky” laws
      of New York and such jurisdictions as the Sellers shall request in writing,
      provided, however, that the Company shall not for any such purpose be required
      to qualify generally to transact business as a foreign corporation in any
      jurisdiction where it is not so qualified or to consent to general service
      of
      process in any such jurisdiction; 

     

    (e)             
       if
      applicable, list the Registrable Securities covered by such registration
      statement with any securities exchange on which the Common Stock of the Company
      is then listed; 

     

    (f)                notify
      the Subscribers within two hours of the Company’s becoming aware that a
      prospectus relating thereto is required to be delivered under the 1933 Act,
      of
      the happening of any event of which the Company has knowledge as a result of
      which the prospectus contained in such registration statement, as then in
      effect, includes an untrue statement of a material fact or omits to state a
      material fact required to be stated therein or necessary to make the statements
      therein not misleading in light of the circumstances then existing or which
      becomes subject to a Commission, state or other governmental order suspending
      the effectiveness of the registration statement covering any of the
      Shares;

     

    (g) 
provided
      same would not be in violation of the provision of Regulation FD under the
      1934
      Act, make available for inspection by the Sellers, and any attorney, accountant
      or other agent retained by the Seller or underwriter, all publicly available,
      non-confidential financial and other records, pertinent corporate documents
      and
      properties of the Company, and cause the Company’s officers, directors and
      employees to supply all publicly available, non-confidential information
      reasonably requested by the seller, attorney, accountant or agent in connection
      with such registration statement; and

     

    (h) 
provide
      to the Sellers copies of the Registration Statement and amendments thereto
      five
      business days prior to the filing thereof with the Commission.

     

    11.3.     
      Provision
      of Documents.
      In
      connection with each registration described in this Section 11, each Seller
      will
      furnish to the Company in writing such information and representation letters
      with respect to itself and the proposed distribution by it as reasonably shall
      be necessary in order to assure compliance with federal and applicable state
      securities laws. 

     

    11.4.     
      Non-Registration
      Events.
      The
      Company and the Subscribers agree that the Sellers will suffer damages if the
      Registration Statement is not filed by the Filing Date and not declared
      effective by the Commission by the Effective Date, and any registration
      statement required under Section 11.1(i) or 11.1(ii) is not filed within 60
      days
      after written request and declared effective by the Commission within 120 days
      after such request, and maintained in the manner and within the time periods
      contemplated by Section 11 hereof, and it would not be feasible to ascertain
      the
      extent of such damages with precision. Accordingly, if (A) the Registration
      Statement is not filed on or before the Filing Date, (B) is not declared
      effective on or before the Effective Date, (C) due to the action or inaction
      of
      the Company the Registration Statement is not declared effective within three
      (3) business days after receipt by the Company or its attorneys of a written
      or
      oral communication from the Commission that the Registration Statement will
      not
      be reviewed or that the Commission has no further comments, (D) if the
      registration statement described in Sections 11.1(i) or 11.1(ii) is not filed
      within 60 days after such written request, or is not declared effective within
      120 days after such written request, or (E) any registration statement described
      in Sections 11.1(i), 11.1(ii) or 11.1(iv) is filed and declared effective but
      shall thereafter cease to be effective without being succeeded within fifteen
      (15) business days by an effective replacement or amended registration statement
      or for a period of time which shall exceed thirty (30) days in the aggregate
      per
      year (defined as a period of 365 days commencing on the Actual Effective Date
      (each such event referred to in clauses A through E of this Section 11.4 is
      referred to herein as a “Non-Registration
      Event”),
      then
      the Company shall deliver to the holder of Registrable Securities, as Liquidated
      Damages, an amount equal to two percent (2%) for each thirty (30) days or part
      thereof of the Aggregate Principal Amount of the Notes remaining unconverted
      and
      purchase price of Shares issued upon conversion of the Notes and exercise of
      the
      Warrants owned of record by such holder which are subject to such
      Non-Registration Event. The Company must pay the Liquidated Damages in cash
      on
      the first trading day of each thirty day or shorter period for which liquidated
      damages are payable. The Liquidated Damages must be paid within ten (10) days
      after the end of each thirty (30) day period or shorter part thereof for which
      Liquidated Damages are payable. In the event a Registration Statement is filed
      by the Filing Date but is withdrawn prior to being declared effective by the
      Commission, then such Registration Statement will be deemed to have not been
      filed. All
      oral
      or written comments received from the Commission relating to the Registration
      Statement must be satisfactorily responded to within
      ten (10) business days after receipt of comments from the Commission.
      Failure
      to
      timely respond to Commission comments is a Non-Registration Event for which
      Liquidated Damages shall accrue and be payable by the Company to the holders
      of
      Registrable Securities at the same rate set forth above. Notwithstanding the
      foregoing, the Company shall not be liable to the Subscriber under this Section
      11.4 for any events or delays occurring as a consequence of the acts or
      omissions of the Subscribers contrary to the obligations undertaken by
      Subscribers in this Agreement. Liquidated Damages will not accrue nor be payable
      pursuant to this Section 11.4 nor will a Non-Registration Event be deemed to
      have occurred for times during which Registrable Securities are transferable
      by
      the holder of Registrable Securities pursuant to Rule 144(k) under the 1933
      Act.

     

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

     

    11.5.     
      Expenses.
      All
      expenses incurred by the Company in complying with Section 11, including,
      without limitation, all registration and filing fees, printing expenses (if
      required), fees and disbursements of counsel and independent public accountants
      for the Company, fees and expenses (including reasonable counsel fees) incurred
      in connection with complying with state securities or “blue sky” laws, fees of
      the National Association of Securities Dealers, Inc., transfer taxes, and fees
      of transfer agents and registrars, are called “Registration
      Expenses.”
All
      underwriting discounts and selling commissions applicable to the sale of
      Registrable Securities are called “Selling
      Expenses.”
The
      Company will pay all Registration Expenses in connection with the registration
      statement under Section 11. Selling Expenses in connection with each
      registration statement under Section 11 shall be borne by the Seller and may
      be
      apportioned among the Sellers in proportion to the number of shares sold by
      the
      Seller relative to the number of shares sold under such registration statement
      or as all Sellers thereunder may agree.

     

    11.6.     
      Indemnification
      and Contribution.

     

    (a) 
In
      the
      event of a registration of any Registrable Securities under the 1933 Act
      pursuant to Section 11, the Company will, to the extent permitted by law,
      indemnify and hold harmless the Seller, each officer of the Seller, each
      director of the Seller, each underwriter of such Registrable Securities
      thereunder and each other person, if any, who controls such Seller or
      underwriter within the meaning of the 1933 Act, against any losses, claims,
      damages or liabilities, joint or several, to which the Seller, or such
      underwriter or controlling person may become subject under the 1933 Act or
      otherwise, insofar as such losses, claims, damages or liabilities (or actions
      in
      respect thereof) arise out of or are based upon any untrue statement or alleged
      untrue statement of any material fact contained in any registration statement
      under which such Registrable Securities was registered under the 1933 Act
      pursuant to Section 11, any preliminary prospectus or final prospectus contained
      therein, or any amendment or supplement thereof, or arise out of or are based
      upon the omission or alleged omission to state therein a material fact required
      to be stated therein or necessary to make the statements therein not misleading
      in light of the circumstances when made, and will subject to the provisions
      of
      Section 11.6(c) reimburse the Seller, each such underwriter and each such
      controlling person for any legal or other expenses reasonably incurred by them
      in connection with investigating or defending any such loss, claim, damage,
      liability or action; provided, however, that the Company shall not be liable
      to
      the Seller to the extent that any such damages arise out of or are based upon
      an
      untrue statement or omission made in any preliminary prospectus if (i) the
      Seller failed to send or deliver a copy of the final prospectus delivered by
      the
      Company to the Seller with or prior to the delivery of written confirmation
      of
      the sale by the Seller to the person asserting the claim from which such damages
      arise, (ii) the final prospectus would have corrected such untrue statement
      or
      alleged untrue statement or such omission or alleged omission, or (iii) to
      the
      extent that any such loss, claim, damage or liability arises out of or is based
      upon an untrue statement or alleged untrue statement or omission or alleged
      omission so made in conformity with information furnished by any such Seller,
      or
      any such controlling person in writing specifically for use in such registration
      statement or prospectus. 

     

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

     

    (b) 
In
      the
      event of a registration of any of the Registrable Securities under the 1933
      Act
      pursuant to Section 11, each Seller severally but not jointly will, to the
      extent permitted by law, indemnify and hold harmless the Company, and each
      person, if any, who controls the Company within the meaning of the 1933 Act,
      each officer of the Company who signs the registration statement, each director
      of the Company, each underwriter and each person who controls any underwriter
      within the meaning of the 1933 Act, against all losses, claims, damages or
      liabilities, joint or several, to which the Company or such officer, director,
      underwriter or controlling person may become subject under the 1933 Act or
      otherwise, insofar as such losses, claims, damages or liabilities (or actions
      in
      respect thereof) arise out of or are based upon any untrue statement or alleged
      untrue statement of any material fact contained in the registration statement
      under which such Registrable Securities were registered under the 1933 Act
      pursuant to Section 11, any preliminary prospectus or final prospectus contained
      therein, or any amendment or supplement thereof, or arise out of or are based
      upon the omission or alleged omission to state therein a material fact required
      to be stated therein or necessary to make the statements therein not misleading,
      and will reimburse the Company and each such officer, director, underwriter
      and
      controlling person for any legal or other expenses reasonably incurred by them
      in connection with investigating or defending any such loss, claim, damage,
      liability or action, provided, however, that the Seller will be liable hereunder
      in any such case if and only to the extent that any such loss, claim, damage
      or
      liability arises out of or is based upon an untrue statement or alleged untrue
      statement or omission or alleged omission made in reliance upon and in
      conformity with information pertaining to such Seller, as such, furnished in
      writing to the Company by such Seller specifically for use in such registration
      statement or prospectus, and provided, further, however, that the liability
      of
      the Seller hereunder shall be limited to the net proceeds actually received
      by
      the Seller from the sale of Registrable Securities covered by such registration
      statement 

     

    (c) 
Promptly
      after receipt by an indemnified party hereunder of notice of the commencement
      of
      any action, such indemnified party shall, if a claim in respect thereof is
      to be
      made against the indemnifying party hereunder, notify the indemnifying party
      in
      writing thereof, but the omission so to notify the indemnifying party shall
      not
      relieve it from any liability which it may have to such indemnified party other
      than under this Section 11.6(c) and shall only relieve it from any liability
      which it may have to such indemnified party under this Section 11.6(c), except
      and only if and to the extent the indemnifying party is prejudiced by such
      omission. In case any such action shall be brought against any indemnified
      party
      and it shall notify the indemnifying party of the commencement thereof, the
      indemnifying party shall be entitled to participate in and, to the extent it
      shall wish, to assume and undertake the defense thereof with counsel
      satisfactory to such indemnified party, and, after notice from the indemnifying
      party to such indemnified party of its election so to assume and undertake
      the
      defense thereof, the indemnifying party shall not be liable to such indemnified
      party under this Section 11.6(c) for any legal expenses subsequently incurred
      by
      such indemnified party in connection with the defense thereof other than
      reasonable costs of investigation and of liaison with counsel so selected,
      provided, however, that, if the defendants in any such action include both
      the
      indemnified party and the indemnifying party and the indemnified party shall
      have reasonably concluded that there may be reasonable defenses available to
      it
      which are different from or additional to those available to the indemnifying
      party or if the interests of the indemnified party reasonably may be deemed
      to
      conflict with the interests of the indemnifying party, the indemnified parties,
      as a group, shall have the right to select one separate counsel and to assume
      such legal defenses and otherwise to participate in the defense of such action,
      with the reasonable expenses and fees of such separate counsel and other
      expenses related to such participation to be reimbursed by the indemnifying
      party as incurred.

     

     

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

    

    (d) 
In
      order
      to provide for just and equitable contribution in the event of joint liability
      under the 1933 Act in any case in which either (i) a Seller, or any controlling
      person of a Seller, makes a claim for indemnification pursuant to this Section
      11.6 but it is judicially determined (by the entry of a final judgment or decree
      by a court of competent jurisdiction and the expiration of time to appeal or
      the
      denial of the last right of appeal) that such indemnification may not be
      enforced in such case notwithstanding the fact that this Section 11.6 provides
      for indemnification in such case, or (ii) contribution under the 1933 Act may
      be
      required on the part of the Seller or controlling person of the Seller in
      circumstances for which indemnification is not provided under this Section
      11.6;
      then, and in each such case, the Company and the Seller will contribute to
      the
      aggregate losses, claims, damages or liabilities to which they may be subject
      (after contribution from others) in such proportion so that the Seller is
      responsible only for the portion represented by the percentage that the public
      offering price of its securities offered by the registration statement bears
      to
      the public offering price of all securities offered by such registration
      statement, provided, however, that, in any such case, (y) the Seller will not
      be
      required to contribute any amount in excess of the public offering price of
      all
      such securities sold by it pursuant to such registration statement; and (z)
      no
      person or entity guilty of fraudulent misrepresentation (within the meaning
      of
      Section 11(f) of the 1933 Act) will be entitled to contribution from any person
      or entity who was not guilty of such fraudulent misrepresentation.

     

    11.7.     
      Delivery
      of Unlegended Shares.

     

    (a) 
Within
      three (3) business days (such third business day being the “Unlegended
      Shares Delivery Date”)
      after
      the business day on which the Company has received (i) a notice that Shares
      or
      Warrant Shares or any other Common Stock held by a Subscriber have been sold
      pursuant to the Registration Statement or Rule 144 under the 1933 Act, (ii)
      a
      representation that the prospectus delivery requirements, or the requirements
      of
      Rule 144, as applicable and if required, have been satisfied, and (iii) the
      original share certificates representing the shares of Common Stock that have
      been sold, and (iv) in the case of sales under Rule 144, customary
      representation letters of the Subscriber and/or Subscriber’s broker regarding
      compliance with the requirements of Rule 144, the Company at its expense, (y)
      shall deliver, and shall cause legal counsel selected by the Company to deliver
      to its transfer agent (with copies to Subscriber) an appropriate instruction
      and
      opinion of such counsel, directing the delivery of shares of Common Stock
      without any legends including the legend set forth in Section 4(i)
      above
      (the “Unlegended
      Shares”);
      and
      (z) cause the transmission of the certificates representing the Unlegended
      Shares together with a legended certificate representing the balance of the
      submitted Shares certificate, if any, to the Subscriber at the address specified
      in the notice of sale, via express courier, by electronic transfer or otherwise
      on or before the Unlegended Shares Delivery Date. 

     

    (b) 
In
      lieu
      of delivering physical certificates representing the Unlegended Shares, if
      the
      Company’s transfer agent is participating in the Depository Trust Company
      (“DTC”)
      Fast
      Automated Securities Transfer program, upon request of a Subscriber, so long
      as
      the certificates therefor do not bear a legend and the Subscriber is not
      obligated to return such certificate for the placement of a legend thereon,
      the
      Company shall cause its transfer agent to electronically transmit the Unlegended
      Shares by crediting the account of Subscriber’s prime Broker with DTC through
      its Deposit Withdrawal Agent Commission system. Such delivery must be made
      on or
      before the Unlegended Shares Delivery Date.

    

    (c) 
The
      Company understands that a delay in the delivery of the Unlegended Shares
      pursuant to Section 11 hereof later than two business days after the Unlegended
      Shares Delivery Date could result in economic loss to a Subscriber. As
      compensation to a Subscriber for such loss, the Company agrees to pay late
      payment fees (as liquidated damages and not as a penalty) to the Subscriber
      for
      late delivery of Unlegended Shares in the amount of $100 per business day after
      the Delivery Date for each $10,000 of purchase price of the Unlegended Shares
      subject to the delivery default. If during any 360 day period, the Company
      fails
      to deliver Unlegended Shares as required by this Section 11.7 for an aggregate
      of thirty (30) days, then each Subscriber or assignee holding Securities subject
      to such default may, at its option, require the Company to redeem all or any
      portion of the Shares and Warrant Shares subject to such default at a price
      per
      share equal to 120% of the Purchase Price of such Common Stock and Warrant
      Shares (“Unlegended
      Redemption Amount”).
      The
      amount of the aforedescribed liquidated damages that have accrued or been paid
      for the twenty day period prior to the receipt by the Subscriber of the
      Unlegended Redemption Amount shall be credited against the Unlegended Redemption
      Amount. The Company shall pay any payments incurred under this Section in
      immediately available funds upon demand.

     

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

     

    (d) 
In
      addition to any other rights available to a Subscriber, if the Company fails
      to
      deliver to a Subscriber Unlegended Shares as required pursuant to this
      Agreement, within seven (7) business days after the Unlegended Shares Delivery
      Date and the Subscriber or a broker on the Subscriber’s behalf, purchases (in an
      open market transaction or otherwise) shares of common stock to deliver in
      satisfaction of a sale by such Subscriber of the shares of Common Stock which
      the Subscriber was entitled to receive from the Company (a “Buy-In”),
      then
      the Company shall pay in cash to the Subscriber (in addition to any remedies
      available to or elected by the Subscriber) the amount by which (A) the
      Subscriber’s total purchase price (including brokerage commissions, if any) for
      the shares of common stock so purchased exceeds (B) the aggregate purchase
      price
      of the shares of Common Stock delivered to the Company for reissuance as
      Unlegended Shares  together
      with interest thereon at a rate of 15% per annum, accruing until such amount
      and
      any accrued interest thereon is paid in full (which amount shall be paid as
      liquidated damages and not as a penalty). For
      example, if a Subscriber purchases shares of Common Stock having a total
      purchase price of $11,000 to cover a Buy-In with respect to $10,000 of purchase
      price of shares of Common Stock delivered to the Company for reissuance as
      Unlegended Shares, the Company shall be required to pay the Subscriber
      $1,000,
      plus interest. The
      Subscriber shall provide the Company written notice indicating the amounts
      payable to the Subscriber in respect of the Buy-In.

    (e) 
In
      the
      event a Subscriber shall request delivery of Unlegended Shares as described
      in
      Section 11.7 and the Company is required to deliver such Unlegended Shares
      pursuant to Section 11.7, the Company may not refuse to deliver Unlegended
      Shares based on any claim that such Subscriber or any one associated or
      affiliated with such Subscriber has been engaged in any violation of law, or
      for
      any other reason, unless, an injunction or temporary restraining order from
      a
      court, on notice, restraining and or enjoining delivery of such Unlegended
      Shares or exercise of all or part of said Warrant shall have been sought and
      obtained
      and the
      Company has posted a surety bond for the benefit of such Subscriber in the
      amount of 120% of the amount of the aggregate purchase price of the Common
      Stock
      and Warrant Shares which are subject to the injunction or temporary restraining
      order, which bond shall remain in effect until the completion of
      arbitration/litigation of the dispute and the proceeds of which shall be payable
      to such Subscriber to the extent Subscriber obtains judgment in Subscriber’s
      favor.

    

    12.       
       (a)                
      Right
      of First Refusal.
      Until
      one year after the Actual Effective Date, the Subscribers shall be given not
      less than ten (10) business days prior written notice of any proposed sale
      by
      the Company of its common stock or other securities or debt obligations, except
      in connection with (i) full or partial consideration in connection with a
      strategic merger, acquisition, consolidation or purchase of substantially all
      of
      the securities or assets of corporation or other entity which holders of such
      securities or debt are not at any time granted registration rights, (ii)
      the
      Company’s issuance of securities in connection with strategic license agreements
      and other partnering arrangements so long as such issuances are not for the
      purpose of raising capital and which
      holders of such securities or debt are not at any time granted registration
      rights,
      (iii)
      the Company’s issuance of Common Stock or the issuances or grants of options to
      purchase Common Stock pursuant to stock option plans and employee stock purchase
      plans described on Schedule
      5(d)
      hereto
      at prices equal to or higher than the closing price of the Common Stock on
      the
      issue date of any of the foregoing, (iv) as a result of the exercise of Warrants
      or conversion of Notes which are granted or issued pursuant to this Agreement
      or
      that have been issued prior to the Closing Date, the issuance of which has
      been
      disclosed in a Report filed not less than five (5) days prior to the Closing
      Date, and (v) the payment of any interest on the Notes and Liquidated Damages
      pursuant to the Transaction Documents (collectively
      the foregoing are “Excepted
      Issuances”).
      The
      Subscribers who exercise their rights pursuant to this Section 12(a) shall
      have
      the right during the ten (10) business days following receipt of the notice
      to
      purchase such offered common stock, debt or other securities in accordance
      with
      the terms and conditions set forth in the notice of sale in the same proportion
      to each other as their purchase of Notes in the Offering. In the event such
      terms and conditions are modified during the notice period, the Subscribers
      shall be given prompt notice of such modification and shall have the right
      during the ten (10) business days following the notice of modification to
      exercise such right.

     

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

     

    (b) 
Favored
      Nations Provision.
      Other
      than in connection with the Excepted Issuances, if at any time while Notes
      or
      Warrants are outstanding the Company shall offer, issue or agree to issue any
      common stock or securities convertible into or exercisable for shares of common
      stock (or modify any of the foregoing which may be outstanding) to any person
      or
      entity at a price per share or conversion or exercise price per share which
      shall be less than the Conversion Price in respect of the Shares, or if less
      than the Warrant exercise price in respect of the Warrant Shares, without the
      consent of each Subscriber holding Notes, Shares, Warrants, or Warrant Shares,
      then the Company shall issue, for each such occasion, additional shares of
      Common Stock to each Subscriber so that the average per share purchase price
      of
      the shares of Common Stock issued to the Subscriber (of only the Common Stock
      or
      Warrant Shares still owned by the Subscriber) is equal to such other lower
      price
      per share and the Conversion Price and Warrant exercise price shall
      automatically be adjusted as provided in the Notes and the Warrants. The average
      Purchase Price of the Shares and average exercise price in relation to the
      Warrant Shares shall be calculated separately for the Shares and Warrant Shares.
      The foregoing calculation and issuance shall be made separately for Shares
      received upon conversion and separately for Warrant Shares. The delivery to
      the
      Subscriber of the additional shares of Common Stock shall be not later than
      two
      (2) business days after the closing date of the transaction giving rise to
      the
      requirement to issue additional shares of Common Stock. The Subscriber is
      granted the registration rights described in Section 11 hereof in relation
      to
      such additional shares of Common Stock except that the Filing Date and Effective
      Date vis-à-vis such additional common shares shall be, respectively, the
      thirtieth (30th)
      and
      sixtieth (60th)
      date
      after the closing date giving rise to the requirement to issue the additional
      shares of Common Stock. For purposes of the issuance and adjustment described
      in
      this paragraph, the issuance of any security of the Company carrying the right
      to convert such security into shares of Common Stock or of any warrant, right
      or
      option to purchase Common Stock shall result in the issuance of the additional
      shares of Common Stock upon the sooner of the agreement to or actual issuance
      of
      such convertible security, warrant, right or option and again at any time upon
      any subsequent issuances of shares of Common Stock upon exercise of such
      conversion or purchase rights if such issuance is at a price lower than the
      Conversion Price or Warrant exercise price in effect upon such issuance. The
      rights of the Subscriber set forth in this Section 12 are in addition to any
      other rights the Subscriber has pursuant to this Agreement, the Note, any
      Transaction Document, and any other agreement referred to or entered into in
      connection herewith. The Subscriber is also given the right to elect to
      substitute any term or terms of any other offering in connection with which
      the
      Subscriber has rights as described in Section 12(a), for any term or terms
      of
      the Offering in connection with Securities owned by Subscriber as of the date
      the notice described in Section 12(a) is required to be given to
      Subscriber.

     

    (c) 
Maximum
      Exercise of Rights.
      In the
      event the exercise of the rights described in Sections 12(a) and 12(b)
would
      result in the issuance of an amount of common stock of the Company that would
      exceed the maximum amount that may be issued to a Subscriber calculated in
      the
      manner described in Section 7.3 of this Agreement, then the issuance of such
      additional shares of common stock of the Company to such Subscriber will be
      deferred in whole or in part until such time as such Subscriber is able to
      beneficially own such common stock without exceeding the maximum amount set
      forth calculated in the manner described in Section 7.3 of this Agreement.
      The
      determination of when such common stock may be issued shall be made by each
      Subscriber as to only such Subscriber.

     

    
      
        
        

      

      
        24

        
          

        

      

      
        
        

      

    

     

    13.        
      Miscellaneous.

     

    (a) 
Notices.
      All
      notices, demands, requests, consents, approvals, and other communications
      required or permitted hereunder shall be in writing and, unless otherwise
      specified herein, shall be (i) personally served, (ii) deposited in the mail,
      registered or certified, return receipt requested, postage prepaid, (iii)
      delivered by reputable air courier service with charges prepaid, or (iv)
      transmitted by hand delivery, telegram, or facsimile, addressed as set forth
      below or to such other address as such party shall have specified most recently
      by written notice. Any notice or other communication required or permitted
      to be
      given hereunder shall be deemed effective (a) upon hand delivery or delivery
      by
      facsimile, with accurate confirmation generated by the transmitting facsimile
      machine, at the address or number designated below (if delivered on a business
      day during normal business hours where such notice is to be received), or the
      first business day following such delivery (if delivered other than on a
      business day during normal business hours where such notice is to be received)
      or (b) on the second business day following the date of mailing by express
      courier service, fully prepaid, addressed to such address, or upon actual
      receipt of such mailing, whichever shall first occur. The addresses for such
      communications shall be: (i) if to the Company, to: The
      Medical Exchange Inc., 17 State Street, New York, NY 10004, with
      a
      copy by telecopier only to: Aboudi & Brounstein, 3 Gavish St., Kfar Saba,
      Israel, Fax: 972-9-764-4834, and (ii) if to the Subscriber, to: the one or
      more
      addresses and telecopier numbers indicated on the signature pages hereto, with
      an additional copy by telecopier only to: Grushko & Mittman, P.C., 551 Fifth
      Avenue, Suite 1601, New York, New York 10176, telecopier number: (212)
      697-3575.

     

    (b) 
Entire
      Agreement; Assignment.
      This
      Agreement and other documents delivered in connection herewith represent the
      entire agreement between the parties hereto with respect to the subject matter
      hereof and may be amended only by a writing executed by both parties. Neither
      the Company nor the Subscribers have relied on any representations not contained
      or referred to in this Agreement and the documents delivered herewith. No right
      or obligation of the Company shall be assigned without prior notice to and
      the
      written consent of the Subscribers. 

     

    (c)              
      Counterparts/Execution.
      This
      Agreement may be executed in any number of counterparts and by the different
      signatories hereto on separate counterparts, each of which, when so executed,
      shall be deemed an original, but all such counterparts shall constitute but
      one
      and the same instrument. This Agreement may be executed by facsimile signature
      and delivered by facsimile transmission.

     

    (d) 
Law
      Governing this Agreement.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of New York without regard to conflicts
      of laws principles
      that would result in the application of the substantive laws of another
      jurisdiction. Any action brought by either party against the other concerning
      the transactions contemplated by this Agreement shall be brought only in the
      civil or state courts of New York or in the federal courts located in New York
      County. The
      parties and the individuals executing this Agreement and other agreements
      referred to herein or delivered in connection herewith on behalf of the Company
      agree to submit to the jurisdiction of such courts and waive trial by
      jury.
      The
      prevailing party shall be entitled to recover from the other party its
      reasonable attorney’s fees and costs. In the event that any provision of this
      Agreement or any other agreement delivered in connection herewith is invalid
      or
      unenforceable under any applicable statute or rule of law, then such provision
      shall be deemed inoperative to the extent that it may conflict therewith and
      shall be deemed modified to conform with such statute or rule of law. Any such
      provision which may prove invalid or unenforceable under any law shall not
      affect the validity or enforceability of any other provision of any
      agreement.

     

    
      
        
        

      

      
        25

        
          

        

      

      
        
        

      

    

     

    (e) 
Specific
      Enforcement, Consent to Jurisdiction.
      To the
      extent permitted by law, the Company and Subscriber acknowledge and agree that
      irreparable damage would occur in the event that any of the provisions of this
      Agreement were not performed in accordance with their specific terms or were
      otherwise breached. It is accordingly agreed that the parties shall be entitled
      to one or more preliminary and final injunctions to prevent or cure breaches
      of
      the provisions of this Agreement and to enforce specifically the terms and
      provisions hereof, this being in addition to any other remedy to which any
      of
      them may be entitled by law or equity. Subject to Section 13(d) hereof, each
      of
      the Company, Subscriber and any signator hereto in his personal capacity hereby
      waives, and agrees not to assert in any such suit, action or proceeding, any
      claim that it is not personally subject to the jurisdiction in New York of
      such
      court, that the suit, action or proceeding is brought in an inconvenient forum
      or that the venue of the suit, action or proceeding is improper. Nothing in
      this
      Section shall affect or limit any right to serve process in any other manner
      permitted by law.

     

    (f)               
      Damages.
      In the
      event the Subscriber is entitled to receive any liquidated damages pursuant
      to
      the Transactions, the Subscriber may elect to receive the greater of actual
      damages or such liquidated damages.

     

    (g) 
Independent
      Nature of Subscribers.  
        The
      Company acknowledges that the obligations of each Subscriber under the
      Transaction Documents are several and not joint with the obligations of any
      other Subscriber, and no Subscriber shall be responsible in any way for the
      performance of the obligations of any other Subscriber under the Transaction
      Documents. The
      Company acknowledges that each Subscriber has represented that the decision
      of
      each Subscriber to purchase Securities has been made by such Subscriber
      independently of any other Subscriber and independently of any information,
      materials, statements or opinions as to the business, affairs, operations,
      assets, properties, liabilities, results of operations, condition (financial
      or
      otherwise) or prospects of the Company which may have been made or given by
      any
      other Subscriber or by any agent or employee of any other Subscriber, and no
      Subscriber or any of its agents or employees shall have any liability to any
      Subscriber (or any other person) relating to or arising from any such
      information, materials, statements or opinions.  The
      Company acknowledges that nothing contained in any Transaction Document, and
      no
      action taken by any Subscriber pursuant hereto or thereto (including, but not
      limited to, the (i) inclusion of a Subscriber in the Registration Statement
      and
      (ii) review by, and consent to, such Registration Statement by a Subscriber)
      shall be deemed to constitute the Subscribers as a partnership, an association,
      a joint venture or any other kind of entity, or create a presumption that the
      Subscribers are in any way acting in concert or as a group with respect to
      such
      obligations or the transactions contemplated by the Transaction Documents. 
The Company acknowledges that each Subscriber shall be entitled to independently
      protect and enforce its rights, including without limitation, the rights arising
      out of the Transaction Documents, and it shall not be necessary for
      any other Subscriber to be joined as an additional party in any proceeding
      for
      such purpose.  The Company acknowledges that it has elected to provide all
      Subscribers with the same terms and Transaction Documents for the convenience
      of
      the Company and not because Company was required or requested to do so by the
      Subscribers.  The Company acknowledges that such procedure with respect to
      the Transaction Documents in no way creates a presumption that the Subscribers
      are in any way acting in concert or as a group with respect to the Transaction
      Documents or the transactions contemplated thereby.

     

    (h) 
Consent.
      As used
      in the Agreement, “consent of the Subscribers” or similar language means the
      consent of holders of not less than 75% of the total of the Shares issued and
      issuable upon conversion of outstanding Notes owned by Subscribers on the date
      consent is requested.

     

    (i)               
      Equal
      Treatment.
      No
      consideration shall be offered or paid to any person to amend or consent to
      a
      waiver or modification of any provision of the Transaction Documents unless
      the
      same consideration is also offered and paid to all the parties to the
      Transaction Documents.

     

    
      
        
        

      

      
        26

        
          

        

      

      
        
        

      

    

     

    [THIS
      SPACE INTENTIONALLY LEFT BLANK]

     

    
      
        
        

      

      
        27

        
          

        

      

      
        
        

      

    

     

    SIGNATURE
      PAGE TO SUBSCRIPTION AGREEMENT

     

    Please
      acknowledge your acceptance of the foregoing Subscription Agreement by signing
      and returning a copy to the undersigned whereupon it shall become a binding
      agreement between us.

     

    
      	 	 	 
	 	
              THE
                MEDICAL EXCHANGE INC.

                a
                  Nevada corporation

              

            
	 
 	 
 	 
 
	
            	By:  	 
	 	
              
Name:
	 	Title:
              
	 	 
	 	 Dated: February _____,
              2007

    

     

    
      
        	
                SUBSCRIBER

              	
                NOTE
                  PRINCIPAL
AMOUNT

              	
                CLASS
                  A 
WARRANTS

              
	
                 

                Name
                  of Subscriber: _________________________

                _________________________________________

                 

                Address:
                  __________________________________

                 

                _________________________________________

                 

                Fax
                  No.: __________________________________

                 

                 

                _________________________________________

                (Signature)

                By:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}]]